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          Today cancer treatment using Intensity Modulated Radiotherapy (IMRT) and 
Volumetric Modulated Arc Therapy (VMAT) is still increasing and spreading in uses 
arround the world. IMRT and VMAT use the MLC to delivery more conformal, highly 
precise and accuracy dose to the tumor. The planning of these modalities is very 
complex, because of that the specific QA programs need to ensure the errors or deviations 
which will affect the dose delivery will be detected and eliminated in order to maximize 
the dose delivered to the tumor and minimize the dose delivered to the OARs, the low 
dose to the OARs reducing tissues complications or damage of the organs. 
           The purpose of this research was to evaluate the MLC parameters reproducibility 
of IMRT/VMAT plans using Electronic Portal Imaging Devices (EPIDs) together with 
its software based on PerFRACTION.  According to the definition of the goal of my 
research, the research based on the pretreatment dose verification.  
           In this study agility MLC from Elekta Synergy linear accelerator installed at 
Tomsk used to delivery 6MV and 10MV photons. Only segment width of the agility 
MLC was considered in this study reproducibility of IMRT and VMAT plans. The plans 
planned by using TPS-Monaco software version 5.11.03 and 3D-CT-images from the 
TG244-Lung patient, TG244-Prostate and TG244-Thorax patient. The total of 12- plans 
were planned in order to get the good results. 4-Plans Planned in each structure (Lung, 
Prostate and Thorax). In this research 2D and 3D-dose analysis also were used for all 
plans and the measurements were carried out with the Electronic Portal Imaging Device 
(EPID) to measure the dose distribution. The EPID is the device that has been 
demonstrating accurate dosimetric capabilities and is currently used in many 
radiotherapy for dosimetric verification including Tomsk Region Oncology Clinic.  The 
analysis was made using Per-Fraction software, which analyzed EPID results in 2D and 
3D-dose analysis in order to detect the errors of the system. Thus, the reference and the 
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measured dose distributions were compared using both gamma analysis and DVH 
analysis. 
          The measurements showed that 3D-dose analysis had been better results than 2D-
dose analysis and the lower point passing rate associated with large value of error. All 
segment width with higher gamma passing that 95% for (2%, 2cGy, TH=10%) criteria 
were good for planning treatment. However the results showed that there was no 
correlation between the gamma analysis and DVHs. In case of 2D and 3D-dose analysis  
some segment width 2D and 3D-dose analysis  are correlated, for example for the lung 
at 1cm segment width  both 2D and 3D-dose analysis had lower point passing rates than 
other segment  width. In case of the MLC errors, the segment width of the MLC can 
affect the dose delivered because the results proved that there were some deviation or 
errors in the segment width of MLC and the results also proved that some segment width 
of MLC associated with the random errors and some segment width of MLC associated 
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        Cancer is characterized by the uncontrolled growth and spread of abnormal cells. If 
this spread is not controlled, it can result in serious illness and death. In 2020 17 million 
new cases of cancer were recorded in the world: 8.8 million (52%) in males and 8.2 
million (48%) in females, giving a male: female ratio of 10:9.3. The World age-
standardized (AS) incidence rate item shows that there are 204.7 new cancer cases for 
every 100,000 men in the world, and 175.6 for every 100,000 females. According to the 
World Health Organization (WHO), in twenty years from 2020 the number of new cases 
of cancer will increase by 70% to more than 22 million cases [1]. The four most common 
types of cancer worldwide are lung, female breast, bowel (including anus) and prostate 
cancers, and account for more than four in ten (43%) of all new cases [2].  Figure (1) 
below represented percentage of New Cancer Cases and the percentage of death of cancer 
patients for both male and female between the age of the 5+ and 85+ years according 
WHO in each continent 
 
Fig 1. (a) Represented % of New Cancer Cases and (b) represented the percentage of 
death of cancer patients for both male and female according WHO in each Continent 
 
          Surgery, Chemotherapy and Radiotherapy among of the modalities used for cancer 
treatment. Surgery is usually done when the tumor is accessible or when organ 
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preservation is not an essential requirement. Chemotherapy uses systemic agents (drugs) 
to kill the abnormal cells which are dividing rapidly. In this way, in several cases 
chemotherapy is used together with surgery and radiation therapy. Radiation therapy 
(radiotherapy) uses ionizing radiation to destroy the cancer cells. Photons, Electron, 
Protons and Heavy ions (e.g.: carbon) are ionizing radiation used in radiotherapy. 
             Currently, treatment of cancer by using modern radiotherapy reducing or 
decreasing dose delivery to the (OARs) and also it increases the dose delivery to the 
cancer cell tissues. Brachytherapy and External Beam radiotherapy are the most common 
types of Radiotherapy which are used for cancer treatment.  Large number of cancer 
patients treated by EBRT which including Intensity Modulated Radiotherapy (IMRT) 
and Volumetric Modulated Arc Therapy (VMAT) and Three dimensional conformal 
Radiotherapy to maximize tumor’s  dose  and minimize  dose to organ at risk(OARs) .  .  
          Technological developments allowed not only conformal methods, such as IMRT 
and VMAT, but also higher prescribed doses, has increased the need for accurate 
procedures during the patient’s treatment to ensure treatment quality or to prevent 
accidents during the treatment. The Quality assurance procedures is  very crucial  for the 
conformal techniques like IMRT and VMAT, fractioned techniques  and single shot 
schemes, machine and patient-specific Quality in order  to avoid major accidents as those 
that have been reported. For example, in 2000, at the National Institute of Panama an 
error related with the data introduced into Treatment Plan System (TPS) resulted in 
continued through a time in treatment. As consequence 28-patients were exposed to 
prolonged irradiation which resulted in 11-deaths due overdose toxicity [3]. In France, 
between 2004 and 2005, 23-prostate cancer patients received an overdose correspondent 
to 7-34% of the realized dose due to an error in dose intensity calculation in TPS. As 
result 5-patients died and the remaining developed serious complications. During one 
year in United Kingdom, 5-patients were exposed to an overdose due to a change in 
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operational procedures and 1-patient died [4]. Among the patients involved in the 
accident, four died and 19 developed serious late complications, including rectal 
inflammation [5].  
               It is not easy to handle QA in IMRT and VMAT plans than for the conventional 
static radiation delivery techniques. Several verification devices such as Arc-CHECK, 
Matri-XX and Octavius (PTW, Freiburg, Germany) [6], have been used for performing 
IMRT or VMAT-QA.  Instead of the verification devices mentioned above, Electronic 
Portal Imaging Devices (EPIDs) introduced in many research for dose checking. The 
EPID performed dose verification in 2D and 3D- dose analysis with or without patient 
of phantom [7-9]. The main goal of pre-treatment patient-specific QA is to verify 
whether the dose distribution produced by the Electron linear accelerator does not deviate 
significantly from the planned.   Many EPID -methods used for dose verification [6].  
            My research worked on pre-treatment QA which focused on detection of 
Reproducibility of IMRT and VMAT plans by using segmental width of MLC for sliding 
window techniques of dose delivering by using EPID together with its software based on 
zero-PerFRACTION Software. In order to identify reproducibility of IMRT and VMAT 
plans, EPID used in this work to perform dose verification for MLC parameters in 2D 
and 3D dose analysis without the actual patient. The gamma index analysis and DVH 
analysis are used to make comparison between the planned and EPID measured dose. 
Different Segment widths of MLC between 0.5 and 2 cm were planned for Lung, Prostate 
and Thorax plans and dose distributions were measured. MLC reproducibility due to 
segment width of the MLC were introduced in the plans in order to check the accuracy 
of the leaf position. 
           Although the work based on pretreatment of specific QA by using EPID panel 
together with its software for IMRT and VMAT plans, also it can be used or applied to 
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check the QA of other delivering techniques which are not involved MLC parameters 
such as 3D-CRT. 
            This research divided in six chapters, Chapter is a theoretical part which include 
background, Purpose of the research, Research questions, Statement of the research 
problem, Limitations and delimitations of the research. Chapter 2 included Equipment 
and materials, chapter 3 is Practical part which included Experiment and procedures, 
Results and discussion of the results, Chapter 4 described Literature Review of the 
Research. Chapter 5 contained the information of the financial management and chapter 
















CHAPTER 1 : THEORETICAL PART  
1.1 Background 
1.1.1 Modern Radiotherapy 
Modern Radiotherapy uses conformal techniques such as IMRT and VMAT to achieve 
the goal of Radiotherapy for maximizing tumor dose and minimizing the dose to the 
OARs in order to avoid tissues damages and other tissues complications by radiation. 
Modern radiotherapy also using fractionation method to deliver the total dose in multiple 
treatments to allow the normal tissues and nearby OAR to recover between fractions. In 
this way, an entire radiotherapy treatment typically consists of 30-40 fractions, 5 times 
per week, which takes approximately 6 or 7 weeks to deliver the total dose prescribed 
[11]. Radiotherapy using EBRT and Brachytherapy to treat tumor. EBRT using high 
energy beams of ionization radiation such as photons, electrons or protons to destroy the 
tumor cells inside the human body and the dose is delivered by a linear accelerator. 
Photon therapy is used in deep tumors, being able to penetrate deep into the body while 
sparing the skin; electron therapy is used for superficial treatments, providing a high dose 
to a few centimeters depth from the skin surface avoiding dose delivery beyond that; and 
Proton therapy delivers energy with extreme precision, therefore limiting unwanted dose. 
In brachytherapy a sealed radioactive source is introduced into or next to the area 
requiring treatment.  
 Clinical Procedure in Radiotherapy  
             The main procedures of EBRT including: clinical evaluation of the patient, 
definition of the patient immobilization system, image acquisition, definition and 
delineation of volumes of interest, treatment planning, pre-treatment patient-specific 
quality assurance, radio-therapeutic treatment and clinical follow-up [21].  
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          The first step consists at collecting the patient’s clinical history and evaluation of 
the extent of pathology, defining accordingly the objective of treatment, curative or 
palliative.  After the initial assessment the immobilization system used to verify the 
position of the patient by finding tumor’s position. Subsequently anatomical images of 
the patient are acquired to plan the radiotherapy treatment. CT is the primary image 
modality used to acquire anatomical images; however, it can be supplemented with MRI 
and/or PET as shown on the figure (1.2) below  
          The Second step is Contouring of anatomical structure.  The aim to separate the 
target Volume and OARs after obtaining anatomical images. The International 
Commission on Radiation Units and Measurements (ICRU) protocol still using for 
volume separation and sets the total dose to administer as well as the dose per fraction. 
The volumes originally defined in the ICRU 50 report [22] as described by figure (1.3) 
below. Delineation of the tumor, OAR, and other anatomical structures are an essential 
for optimization and selection of the beams and other requirements for planning. This 
will in turn ensure that tumor’s volume received 95% of the dose delivered in it.  
 
 




Fig 1.2.Siemens CT-Simulator  used fo acquization of anatomical  images 
 
Fig 1.3. Schematic representation of the volumes defined in ICRU Report 50 [15] 
              
           The GTV corresponds to the palpable or visible tumor extension, where the 
location of tumor cells is considerably higher. In turn, the CTV corresponds to a volume 
of tissue that contains the GTV and an additional margin associated with sub-clinical 
tumor extent, which includes microscopic tumor spread in the GTV limit. This volume 
considers, in addition to internal variations driven by mobility and anatomical changes 
of internal organs, the external variations that specifically correspond to uncertainties 
related to patient positioning, tumor’s position and alignment of the radiation beam.  The 
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treated volume (TV) is the volume of tissue enclosed by an iso-dose surface selected and 
specified by the clinician as being appropriate to achieve the aim of treatment, i.e., cure 
or palliation. The TV should not be significantly larger than the PTV. OARs these are 
organs or structures which are closer to tumor. Any movements OAR or uncertainties of 
set-up may be accounted for with a margin similar to the principles for PTV. The 
irradiated volume (IV) is the tissue volume receiving a radiation absorbed dose that is 
considered significant in relation to normal tissue tolerance. This concept is not often 
considered in practice but may be useful when comparing one or more competing 
treatment plans. Clearly, it would be preferable to accept the plan with the smallest IV, 
all else being equal [22]. 
 Treatment planning system (TPS) 
          TPS is a computer software that receives patient information to generate planning   
according to the dose constraints that each tissue could have. It is also capable of making 
plan evaluations through DVHs and transferring the plan to the treatment machine. Dose 
calculations have evolved from 2D models to 3D models and from there to 3D Monte-
Carlo simulations.  
           The patient information is then stored in a medical imaging standard format, 
namely DICOM. DICOM-RT is specific for radiotherapy and incorporates different 
types of information such as: RT Structure, which contains the delineation of the relevant 
structures; RT Plan, with all the dosimetric and geometric information of the treatment 
plan; RT dose, for distributed dose are obtained through TPS [23].  
          It is important to mention that the RTP is a file format also used in radiotherapy 
for exporting and importing information about treatment planning data. This file may not 
contain as much information as the DICOM-RT Plan, but it is used by the LINAC to 
deliver the treatment. Due to the different technique, the TPS uses different methods to 
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calculate dose. The 3D-CRT technique uses forward treatment planning that requires a 
previous choice of specific parameters such as beam selection, energies, and MLC 
configuration, before dose calculation.  IMRT technique is the “inverse” treatment 
planning, which introduced to predefine the number of dose restrictions corresponding 
to each type of tissue and the prescription dose. The software then automatically 
calculates the optimal beam modulation for the aim to match the chosen thresholds or 
criteria [24]. There are many TPS software such as eclipse TPS, Pinnacle TPS and e.t.c 
but this work focused on Monaco-TPS software for treatment planning for planning and 
dose calculation. 
 Radiotherapy Delivery Techniques  
         There are many delivery techniques used in radiotherapy departments to execute 
the dose delivering including 2D-convetional therapy, 3D-CRT. In case of having 
irregular PTV, 3D-CRT is not capable of separating PTV dose from the healthy tissues 
[14-17]. This work dealing with IMRT and VMAT modality due to the sliding window 
mode of dose delivery. IMRT and VMAT using MLC to deliver the accuracy and 
maximum dose to PTV and lower dose to the OAR [17]. The MLC is controlled 
automatically by computer, and allows for achieving the desired conformation/field 
geometry and modulation of the beam intensity.  
          In dynamic MLC mode, dose through IMRT delivered by continuously the leaves 
movement of the MLC at a constant or fixed gantry angle.   The fluence distributions are 
adapted to the treatment constraints of the patient and each radiation beam is modulated.  
With these dynamically shaped fields, the distributed dose can be more conformal to the 
tumor.  
            The VMAT technique was introduced in 2007 by Karl Otto [18] and uses sliding 
window(dynamic MLC) mode, to deliver dose by continuous rotation of the gantry 
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around the patient and dose is distributed simultaneously region of the interest (ROI). 
The VMAT technique allows the irradiation from all angles in one or more rotations of 
360◦ around the patient. During that beam shaping is defined by leaves of the MLC while 
the intensity modulated is obtained through multiple rotational arcs. In this way, the 
gantry is making a complete or a partial arc. VMAT can deliver more conformal 
distributed dose by continuously and simultaneously varying gantry angle, field shape 
and dose rate during treatment [19].  The major advantage of VMAT over IMRT fixed 
angle is increasing of delivering efficiency due to large efficient of time used and 
reduction of number of MU. The reduction in treatment delivery time is an extremely 
important factor since it reduces the occurrence of potential motion and discomfort of 
the patient, minimizing set-up variations. Analyzing of three distributed dose from the 
3D-CRT, IMRT and VMAT techniques as shown on the figure (1.5) 
 
Fig 1.4.Dose distributions: (a) 3D-CRT, (b) IMRT and (c) VMAT techniques  
 Depth dose  
          It is important to define the SI unit responsible for describing the amount of energy 
deposited in tissues. This quantity is denoted by Gray (Gy), and is equivalent to 1 Joule 
per kilogram (1 Gy = 1 J/Kg). Therefore, the absorbed dose ii expressed by the quotient 
of the average energy transmitted by ionizing radiation (dE) and the corresponding mass 
(dm): 
                                     𝐷 =
𝑑?̅?
𝑑𝑚
                                                       (1) 
a b c 
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           The basic principle inherent to external radiotherapy is the use of an ionization 
source that is located from the patient at some distance. It is essential to understand the 
way the radiation is absorbed to the patient. 
             The inverse square law used to express the propagation of the megavoltage 
photon beam through air or vacuum, between the energy per unit area and distance. The 
law stated that the intensity of radiation (I) at a specific point is inversely proportional to 
the square of the distance from the source (d) and is given 
                            𝐼 ∝
1
𝑑2
                                                          (2) 
               In a patient or a phantom used to simulate the effect of dose distributed, besides 
the inverse square law, there are other factors, such as the attenuation and photon 
scattering which are responsible for the curve’s shape of the dose deposition along the 
depth (Figure 1.4). 
 
Fig 1.5. Deposited dose in a patient. 𝑫𝒔is the surface patient’s dose, at- 𝒛𝒎𝒂𝒙 depth, the 




          The photon beam enters at the patient surface and delivers an amount of dose𝐷𝑠 . 
As the beam penetrates the deposited dose increases until a certain depth𝑧𝑚𝑎𝑥 . From that 
depth the dose decreases almost exponentially until it reaches a value 𝐷𝑒𝑥 at the patient 
exit point. The maximum absorbed dose depends mainly on beam energy and absorbent 
material, but also on the field size. 
 Quality Assurance 
              With the increasing complexity of Radiotherapy techniques, it becomes more 
important to ensure the delivery of the prescribed doses within accepted criteria since an 
incorrect delivery of megavoltage energy beams may lead to serious damage to healthy 
tissues. Therefore, dedicated Quality Assurance (QA) programs are required to ensure 
that treatments is more quality and the safety of the patients.  Machine-specific QA and 
patient-specific QA are kinds of QA involved in radiotherapy department. Machine-
specific QA allows checking whether the machine characteristic do not deviate 
significantly from their base line values of commissioning. Depending on each specific 
machine functionality (such as output, MLC position, couch, gantry rotation, and jaws 
motion and beam quality) these QA programs are performed at different frequencies 
(daily, weekly, monthly and annually). Patient-specific QA ensure the quality of each 
individual patient plan, specifically for conformal techniques (IMRT, VMAT and 
SBRT). These QA programs can be performed priori or during the treatment session and 
due to that it is better to differentiate vivo patient-specific QA from pretreatment QA. 
            The main purpose of pre-treatment patient-specific QA is to verify whether the 
delivered the distributed dose does not deviate significantly from the dose planned of the 
LINAC, before the treatment session to be started. If the deviations occurred due to the 
distributed dose is beyond the defined acceptance criteria, the recalculation of the dose 
distributed is required. In vivo patient-specific QA allows the comparison between the 
measured and planned dose when patient is used. 
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        In Radiotherapy Departments, pre-treatment patient-specific QA is more common 
than in vivo and it is usually performed by applying the plan to 2D or 3D phantom 
distributed dose. These measurements may be performed using ionization chambers, 
thermo-luminescent detectors or diodes at a single or multiple point. Although the 2D 
devices such as diode or ionization chamber arrays contain more measurement points, a 
resolution higher than 1 cm is rarely achieved. In turn, film measurements provide high 
resolution but require digitization of the measured data which is time consuming. In 
addition to high resolution of the digital data, the electronic portal imaging device (EPID) 
allows speed-up of acquisition of the data, reason why their potential to perform pre-
treatment dosimetric verification has been explored. 
1.1.2 Electronic Imaging Devices (EPIDs) and EPID dosimetry  
             Electronic portal imaging devices were originally developed for verification of 
patient positioning during treatment and to replace film that was previously used. The 
portal images of the megavoltage treatment beam acquired by the EPID used to indicate 
uncertainties in the patient set-up or errors of the radiation field placement prior or during 
field delivery. In clinical practice EPID as a tool for set-up verification measurements of 
the patient position, it was realized that EPID images also contained dose information 
[25]. Consequently, it has become more advantageous than other dosimetric device used 
for dose verification.  
             Several types of EPIDs designed and classified for dose verification. First EPID 
being commercially available was the liquid-filled ionization chamber EPID (Li-Fi 
EPID), followed by the camera-based EPID (CC-based EPID) and, more recently, the 
amorphous-silicon EPID (a-Si EPID) which currently is the most used [10]. 
            The EPID is a device attached to the LINAC and placed at 160cm from the head 
of the LINAC, as shown on figure 1.2. EPID measures the intensity of the radiation 
delivered to the patient during treatment by acquiring portal images [26]. During the 
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irradiation a frame (signal from one readout of the entire panel) is taken every two 
seconds, approximately. The EPID signal is calculated by multiplying the average pixel 
value and number of frames acquired. Before obtaining the total EPID signal, each 
individual frame is corrected for individual pixel sensitivity and offset. The corrected 
image 𝐼𝑝𝑟𝑜𝑐 is giving by [27]: 




          Where the 𝐼𝑟𝑎𝑤 is the average of all frames or each frame individually, 𝐼𝑑𝑎𝑟_𝑑𝑦𝑛 is 
a dynamic dark image acquired every 30 seconds when the EPID is not being irradiated. 
The 𝐼𝑓𝑙𝑎𝑡is an open field image delivered to the entire sensitive area that accounts for 
individual pixel sensitivities (response) and corrects their differences. The 𝐼𝑓𝑙𝑎𝑡 and 𝐼𝑑𝑎𝑟𝑘  
are acquired when EPID is installed or when some changes in the set-up are made. 
Variations in the dark field current introduce an offset to the pixel signal. This procedure 
was developed to optimize image quality [27, 28] 
 A-Si EPID 
          The a-Si EPID is new model form of EPID using for dose verification centers and 
first described by Antonuk et al. in 1996. A-Si-EPID is the two-dimensional matrix of 
image pixels device that convert X-ray to digital image [10, 29].   A-Si EPID-iView-GT 
is an example of an A-Si EPID used from Elekta.  It is a flat panel imager with a sensitive   
surface of 40 cm x 40 cm of amorphous silicon-photodiode detector. The EPID-iView-
GT has in total 1024 x 1024 pixels; each pixel (picture element) of the active-matrix 
consists of a light sensitive photodiode and a field-effect transistor (a-Si-FET). The 
photodiode is responsible for the detection of the visible light emitted by the phosphor 
screen in the form of electric current while the FET acts as a switch to control the readout 
of the generated charge [29]. The surface elements collect the dose that falling on EPID 
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panel and X-ray converter converting the dose transmitted from the patient into the 
corresponding number of electrons and is a copper plate attached to a phosphor screen is 
also responsible for absorbing the radiation that is diffused from the patient. For the 
further process, the electrons are change into electrical signals by using imaging tools 
finally portal image is acquired. 
 EPID Dosimetry  
          Besides their application as imaging detectors, the EPIDs also used planar dose 
detectors. In EPID dosimetry (portal dosimetry), there are different EPID dosimetry 
methods based on whether the radiation beams passing or not transmitted through an 
attenuating medium (a phantom or patient.  These methods used to verify the dose 
distributed to the patient or phantom. Non-transit images are a valuable tool for 
performing quality control of treatment parameters included LINAC’s dosimetry 
characteristics, such as symmetry of the beam, the absolute output of LINAC or MLC 
leaf positions or trajectory.  
           EPID dosimetry can be arranged in different forms of verification, as represented 
on the figure (1.6) [10].  At the EPID level the acquired portal image, which can be in 
grayscale values or converted to fluence or dose values depending on the approach used 
defined the 2D-dose analysis and predicted EPID response or distributed dose can be 
calculated at the EPID by a specific algorithm. Another verification is done by EPID is 
reconstructing dose distributed inside the body or phantom (volume elements) and portal 
image obtained by EPID through CT-image, and then compared to TPS [10] 
         EPID measurements can be performed with minimum set‐up requirements and a 
2D delivered dose conversion can be done immediately using the digital images acquired. 
Although an EPID image contains 2D and not 3D information, it is still possible to 
produce 3D dose analysis inside a patient or more recently, time-resolved or 4D dose 
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distributions [10]. In this way, EPID dosimetry allows dose verification in: 1D, 2D, 3D, 
and 4D or time-resolved. The portal dose dosimetry involved several steps in to obtain 
the portal dose.  Step one is to acquire the planned dose and data from the TPS (e.g. 
planning CT) which will be compared with EPID measured dose. The planned dose and 
TPS data, point dose, planar dose (2D) or the 3D or 4D planned dose distributions are 
calculated with a prediction model.  Step two, when the treatment is being delivered the 
EPID images acquired need to be converted into portal dose images [7, 12, 31]. Then, 
the 2D portal dose images recombined to produce 3D or 4D dose distributions.  
             Finally, it is necessary to do a quantitative comparison between the measured 
dose distributed and the planned (predicted) dose distributed using a dose comparison 
method. The most commonly used quantitative dose comparison method is the gamma 
evaluation [32, 33, and 34]. 
 
 
Fig 1.6.Methods of arrangements of EPID dosimetry [10] 
1.1.3 Advantages and disadvantage of the Dosimetric system  
           The EPID provides more sensitivity method of determining radiation field 
placement accuracy. It is capable of capturing images at every treatment and even 
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multiple images during each treatment with little effort.  Portal Dosimetry as a pre-
treatment verification tool is that the fields are measured separately.   
              The disadvantages of the EPID.  MLC position, dose rate (D R) and GS (gantry 
speed) as a function of time cannot obtained directly from the EPID.  It cannot provide 
the acquire images of step-and-shoot fields easily than you expected. Furthermore, it 
would be desirable to use Portal Dosimetry for in vivo dosimetry. It does not give a 
verification that the TPS has correctly calculated the dose distribution, it does not give 
much information about the total dose distribution. 
1.2 The purpose of the study   
 Main objective of the study  
        The main objective of this research was to evaluate MLC parameters reproducibility 
of IMRT and VAMT plans using EPID together with its software based on 
PerFRACTION software.  
  Specific objectives of the research 
 To understand the relationship between the gamma passing rate and 
reproducibility 
 To find the suitable segment width in each localization  
 To investigate the correlation between 2D and 3D dose analysis  
 To investigate the correlation between gamma index analysis and DVH 
analysis. 
 To study the relationship between the MLC parameters and EPID  
1.3 Research Questions or problems of the research  
 What the impact to the dose delivered if the MLC parameters either would be 
increased or increased? 
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 How you can estimate or measure the MLC parameters reproducibility of IMRT 
or VMAT plans? 
 What is the directly correlation between the MLC parameters and electronic 
portal imaging detector? 
 What is comparison and correlation between the 2D and 3D-dose distribution? 
 Which structure produce large reproducibility than other and why? 
1.4 Problem statement of the Research  
       The purpose is to evaluate the MLC parameters reproducibility of IMRT/VMAT 
plans. The problem is that there are possibilities of MLC parameters reproducibility 
affect the dose delivery to the patient using IMRT/VMAT plans during the treatment 
planning.  
         The problem was solved by using the segment width of MLC to verify the 
distributed dose on PTV and detected it by EPID detector. The data from EPID analyzed 
into dose by using PerFRACTION software which display the results quantitatively and 
distributed dose analyzed by gamma evaluation method for comparing the dose delivered  
and expected dose in each segment width through 2D- gamma index analysis and 3D-
gamma analysis (DVHs) in order to provide timely and efficient interventions for the 
correction of under-dose and overdose.  
1.5 Significance of the study 
 The study of the evaluation of the MLC parameters reproducibility of IMRT 
and VMAT plans helps us to find the better way of achieving more conformal, 
precise and accuracy dose to the PTV if planning associated with large value 
of reproducibility. 
 It can solve the problem of quality assurance by using other MLC parameters 
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 It can help the radiotherapy department to understand the procedures of using 
EPID for quality assurance in order to save the time. 
 It can help the radiotherapy department how to plan and performing the quality 
























CHAPTER 2 : MATERIALS AND METHODS 
2.1 Equipment and Materials  
2.1.1 Elekta Synergy Linear Accelerator Machine      
          Elekta Synergy accelerator is produced by Elekta Company and can provide 
electron and Photon beams. Accelerator may be used to irradiate a very complex targets 
in Three-dimensional conformal and Intensity Modulated plan.  Elekta Synergy is a 
digital linear accelerator that has capable of delivering 4 MV, 6 MV and 10 MV, 15 V 
and 18 MV photons.  
           In research, Elekta Synergy linear accelerator installed at Tomsk Regional  
Oncology Clinic, use as source of Mega Voltage X-ray photons which produced 6mv 
and 10MV photon.  All the procedures and plans in this study done by using Elekta 
Synergy Linear accelerator Installed at. It is equipped with agility Multi-leaf collimator 
which shapes and modulates beam and EPID imaging detectors (XVI and a-Si- EPID-
iView-GT) for image capturing and storing.  
           Elekta MLC containing a 160 inter-digitating leaves and single focused MLC leaf 
pairs have a minimum separation of 5mm each at iso-cenetr and 95% of the leaves made 
up by tungsten materials and have average transmission < 0.5% and have maximal 
interleaf leakage< 2%. Each MLC leaf can travel with a maximal leaf speed of 3cm/s 
and maximum carriage leaf speed of 3.5cm/s and it can travel beyond the central axis by 
-15cm up 20cm to a total distance of 35 cm to produce a maximum open field with area 
of (40 x 40)𝑐𝑚2.  Dosimetry leaf gap as the function of MLC, so the maximum Dynamic 
leaf gap is 1mm and leaves can shape the beam up to end leaf radius 170mm.  
           Elekta synergy interacting with two EPID imaging detectors (XVI and a-Si- 
EPID-iView-GT).  EPID-XVI is 2D, 3D and 4D kV-CBCT X-ray volume imaging 
detector which used in the planning and treating in 2D and 3D verification. The 3D 
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imaging capability of XVI enables clinicians to handle complex cases without using 
markers to visualize soft tissues structures, target volume and position of critical 
structure. XVI provides low dose volumetric 3D data sets with sub-millimeter isotropic 
resolution, obtained from patient in the treatment side. The system can acquire a 
complete 3D volume in a partial or complete gantry revolution with reconstruction taking 
place simultaneously. The XVI software offers the flexibility to vary the dose necessary 
to acquire a volume view image by considering the level of contrast required.   
          A-Si-EPID is a flat panel imager composed, active detector surface of 40cm x 
40cm covered by amorphous-Silicon photodiode and positioned at a source-Detector 
surface distance (SDD) of 160cm form the treatment head for the treatment as shown on 
the figure 2.1 below. Each frame is a scan of the detector elements and this EPID has a 
total of 1024 x 1024 pixels; each pixel (picture element) consisting of a light sensitive 
photodiode and a thin film transistor to enable readout [34]. The surface elements collect 
transmitted beam that reached on them and convert that it into the electron density. The 
electron density are then changed into electrical signals which are continuing processed 
by the imaging tools to the portal image. Elekta a-Si EPID used IView-GT software to 
capture or acquire, to store and convert portal images and portal dose image.  The portal 
obtained by delivering a photon beam from an Elekta Synergy LINAC to the Elekta 
iView-GT a-Si EPID and then delivered images compared expected portal images.   In 
my research portal images obtained by varying the source to EPID detector distance for 




Fig 2.1. (a) Elekta Synergy Machine together with its EPID and (b) Elekta Agility MLC 
2.1.2  TG244-Patients  
         Because no actual patient used in the work, so all plans done by using 
TG244_patient folder which contains the 3D-DICOM-CT scan images and RTP 
localization sets of various parts of the body associated with its total dose, dose 
fractionations used for treatment planning. My research used TG244-Lung cancer 
Patient, PTG244-Prostate cancer Patient and TG244_Thorax Cancer Patient planning. 
These TG244- patients contained CT-images of the lung patient, prostate patient and 
Thorax patient corresponding to its dose description for each structure and for each 
patient which used  for planning IMRT and VMAT at a dose threshold of 10% and 
threshold gamma passing rate of 95% for (2%, 2mm) criterion as represented as shown 
on the table 3.1 below 
Table 2.1− TG244-Lung, TG244-Prostate and TG244-Thorax Patient 
 
TG244-Patient 




Dose/Fraction  Global 
Passing 
rate 
Lung-PTV63 63 35 1.8 95% 
ProstatePTV60 60 30 2 95% 






2.1.3 TPS-Monaco software version 5.11.03  
           This work used the TPS- Monaco software version 5.11.03 for planning, 
delivering and data collection treatment planning, dose delivering and data collection.  
The TPS – Monaco software is among of the Elekta software that uses Monte Carlo for 
photon beams algorithms, the accuracy dose mode calculation available.  This software 
uses physical and biological cost functions that allow the modeling of tissues to dose 
response.  It uses a multi-criteria optimization that automatically to get low dose to the 
health tissues without compromising PTV coverage. In relation to IMRT/VMAT plans, 
the dose deposition is made from several oblique radiation fields, called anterior right 
and left and oblique posterior right and left along the beam’s direction. After performing 
dose calculation, Monaco is capable of creating DVHs and percentage passing rate for 
OARs and tumor volumes. Monaco is connected to Elekta-TPS, which is a patient 
oncology information management system.  The connected TPS – Monaco software with 
the treatment machine by allowing the transference of patient information such as the 
treatment plan. 
 

















2.2.1  Segment width of the Dynamic MLC  
             The aim was to evaluate the MLC parameters reproducibility of IMRT and 
VMAT plans by EPID together with its software.  The work’s goal can be achieved by 
the segment width of sliding window of MLC mode used to perform dose delivering. 
The segment width was achieved by leaves position of MLC and then dose to the target 
obtained when leaves are “ON”.   In this work, the varying segment width from 0.5cm 
to 2cm were used to shaped and modulated beams according to PTV.  Finally dose was 
delivered through these segment widths of Dynamic MLC and hence the MLC 
parameters reproducibility will be assed.  
2.2.2 2D and 3D-EPID Dosimetry based on PerFRACTION Method 
     The experiment worked on 2D and 3D-dose analysis by EPID without patient. In 2D-
dose analysis, image portal dose determined when the dose distributed at the surface area 
(pixels) EPID panel. In this method the Expected image portal dose from EPID and 
delivered dose image compared by using gamma analysis method. 
       In 3D-dose distribution dose was measured by combining the 2D information due to 
the back-projection reconstruction of the point dose, the aim of 3D here to reconstruct 
dose volume from volume element and EPID dose is compared to TPS-dose [36-41]. 
This reconstruction method used EPID images without the patient placed in the beam 
and algorithm of calculating dose does not dependent a Monte Carlo dose engine. The 
method involved four steps until the final dose calculation as shown on the Figure 2.6. 
First step, a portal image is captured in the same procedures as real treatment and is 
converted into a portal dose image using a-Si EPID-iView-GT [23]. Second step is to 
extract from this portal dose image the energy fluency exiting the LINAC. As a third 
step, a phase space distribution is sampled from the energy fluence. In the final step, the 
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reconstructed phase space distribution is the starting point for the dose calculation. The 
3D dose calculation is performed inside the patient planning CT.  
 
Fig 2.6. Schematic representation of the several steps involved in the model used for 3D 
in vivo dosimetry. In a first step the 2D open-field portal dose images acquired by the 
EPID from all beam directions are converted to energy Fluence. 
 
 
Fig 2.7. Workflow of the 3D portal dose measurement acquisition and extraction of dose 
metrics from the DVH and gamma evaluations. 
           
        The work used PerFRACTION software to analyze the EPID measurements 
quantitatively. In 2D-EPID dosimetry the results analyzed in gamma index analysis (2D 
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gamma analysis) and in 3D-EPID, the results analyzed in DVH analysis (3D gamma 
analysis) as shown on the figure (2.7) 
          The PerFRACTION (PF) system is an automatic complex part of SunCHECK 
platform for monitoring the irradiation quality of each fraction delivered to a particular 
patient. It reconstructed dose, and the dose predictions of the planning  where compared 
The system has the following features, log files of the linear accelerator, CBCT images, 
and portal imaging of the EPID panel. Due to the information above, the built-in Sun 
Nuclear Dose Calculator, graphics processing unit, accelerated Collapse Cone 
Convolution/Superposition (CCC) algorithm – performs an independent calculation of 
distributed dose. This algorithm uses a beam model created by Sun Nuclear Corporation.     
           The dosimetric plan developed by the TPS in the DICOM format was transferred 
to the Per-fraction server. The data includes a set of CT images, a set of structures and 
individual dose characteristics of the beams. After receiving incoming data, the 
DoseCHECK module a part of the SunCHECK platform that was used for pretreatment 
verification automatically provides independent quality assessment of the planning 
system by recalculating beam doses using CCC-algorithm. The results are presented as 
a comparison of Planned by TPS and Calculated (QA) doses by point dose and 3D-point 
distributed in structure.  The pre-treatment QA is made without the presence of a patient 
(zero-fraction). The treatment plan is fully reproduced with the collection of EPID-
images. The obtained images are analyzed by the gamma index method compared to the 
“expected” ones and are used to form a 3D dose distribution. In vivo dosimetry of each 
fraction uses daily CBCT and EPID images of the patient in combination with the 
accelerator log files. All EPID images obtained at the first fraction are selected as a base 
(baseline). All subsequent images are automatically compared to the baseline. EPID 
results due to the distributed dose on the structures of the patient analyzed by 2D-and 
3D- gamma analysis method. 
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2.2.3 Gamma evaluation method 
  The gamma evaluation method is a method by which the planned dose and dosed 
measured can be compared in a quantitative manner in the dose and spatial domains [2, 
24].The method uses two criteria simultaneously, a distance to agreement (DTA) and 
difference of dose (DD) which are complementary with overdose and under-dose area, 
to find the gamma value for each surface element and volume element as shown on figure 
3.4. Therefore, in clinical practice a number of different evaluation ways applied to 
compare distributed dose such as profile comparisons, gamma evaluation method and 
e.t.c.  
Dose difference (DD). DD is the most intuitive and straightforward quantitative 
evaluation method in which the dose difference between two points of distributed dose 
can be calculated as a dose domain. In this way, considering a point in the reference dose 
distribution (𝑟𝑚) and the corresponding point in estimated dose distribution (𝑟𝑐) the DD 
is given by expression below  
∆𝐷 = 𝐷𝐷 = 𝐷𝑐(𝑟𝑐) −  𝐷𝑚(𝑟𝑚),                                      (3) 




)  𝑥 100%,                                   (4) 
 DD criterion (∆D) is set such that the points with a dose difference value higher than 
fail the criterion and the points with a dose difference value lower than ∆D pass the 
criterion. In clinical practice normally ∆D% of the maximum dose. Although this method 
is considered clinically significant for low-dose slope areas, it is inadequate to evaluate 
high-dose surface areas since a small spatial shift in the alignment can translate into a 
large difference in dose.  
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Distance-to-Agreement (DTA). DTA is the distance between a points in a calculated 
distribution 𝑟𝑐⃗⃗⃗and the closest point in the measured distribution 𝑟𝑚⃗⃗ ⃗⃗ ⃗⃗  that indicates the same 
dose. The DTA is given by the expression 1. 
𝐷𝑇𝐴(𝑟𝑐) = 𝑚𝑖𝑛|𝑟𝑐 − 𝑟𝑚|,                                              (5) 
             In order for a part of the image to pass it would have to have a DTA lower than 
the chosen criteria (∆d mm). The DTA method is suitable in high gradient surface 
whereas the dose-difference method is suitable in low gradient surface as shown in the 
figure. A DTA criterion (∆d mm) is also set, and the points with a DTA value at higher 
than ∆d fail the criterion and the points with a DTA value lower than ∆d pass the 
criterion. Unlike the DD, the DTA method is sensitive in high-dose gradient regions. 
However, for the low-dose surface the DTA method can display area of disagreement 
large than the DTA criterion, defined as clinically acceptable criterion, for relatively 
small dose differences. The gamma evaluation method combines the features of dose 
difference and DTA methods, which complement each other.  
         An ellipsoid on figure 2.8 is used as the surface representing the acceptance criteria 
for gamma evaluation as represented by equation 7. Knowing that r represents the spatial 
location and δ the difference in dose between the evaluated and reference distributions 




Fig 2.8. Geometric representation of Gamma evaluation method using the combined 
ellipsoidal  absolute dose difference and DTA. The x and y axes show the dircteion of 
distributed points in the evaluated distribution (?⃗⃗?𝒄) relative to the  the reference point 
distributed (?⃗⃗?𝒎) 






,                                                      (6) 
𝛾(𝑟𝑐) = min{ г(𝑟𝑐 , 𝑟𝑚)} ∀{𝑟𝑚}.                                                        (7) 
Were ∆𝐷 is the dose difference, DTA- distance to agreement.  
%γ (%∆𝐷, ∆𝑑(𝑚𝑚)) ≤ 1, calculation passes                                 (8) 
   %γ(%∆𝐷, ∆𝑑(𝑚𝑚))> 1, calculation fails                                    (9) 
           The surface of the image that fulfil either criteria would then pass and parts of the 
image that would not fulfil this criterion will not pass and hence through either 
expression 8 or expression 9 above the two dose distributions would be compared.  
        The work used gamma evaluation method of passing rate of %γ (2%, 2mm) ≥ 95% 
criterion at dose Threshold of 10% and %γ (3%, 3mm) ≥ 95% criterion at dose Threshold 




CHAPTER 3 : PRACTICAL PART 
3.1  Procedures and Experiment of IMRT/VMAT plans Verifications   
         Research based on experiment of the IMRT and VMAT verifications.  The plans 
created by TPS by including gantry angle, MLC setting and number of monitor and the 
plans were done in accordance with Elekta synergy specifications including 6MV and 
10MV photon beam and all plans planned by using TPS-Monaco software version 
5.11.03. After plans delivered to the imager in air without phantom or patient or any 
attenuating medium between the source of the radiations and EPID after created as shown 
in figure 3.1. The actual patient not involved in the process. Instead of that, the tested 
plans were done by emulated patient plans in 3D-CTimages from a TG244_Lung patient, 
TG244_Thorax patient and TG244_Prostate patient plans and Portal dose image of each 
segment width between 0.5 cm and 2cm in each structure was measured by converting 
portal image captured into portal dose image by using EPID associated with its software.  
         The portal dose images of both plans were measured at  different SDD less than 
100cm and the evaluation was performed in the portal dosimetry review workspace with 
a (2%, 2mm) gamma analysis at a dose threshold of 10% for a threshold gamma passing 
rate was set at 95%. And at this condition the acquired portal dose image and predicted 
dose image was compared. A total of 12-plans were planned .4-Plans planned in each 
structure as. All lung and Prostate plans planed with zero degree (0°) of couch angle and 
zero degree (0°) of and all thorax plans planned with 345° of collimator angle and 345° 
of couch angle as shown on table and the final results analyzed by per-fraction software 






Table 3.1− Plans created for Lung, Prostate and Thorax patients 
 




Table 3.3− Plan Parameters applied for Prostate plan measurement 
Structure  
Energy  


















VMAT 0.5 1a005 895.7 180 0 333.5 1.114 
2a005 883.6 5 0 415 0.957 
VMAT  
1 
1B010 895.7 180 0 301 0.961 
1B010 883.6 5 0 378.9 1.105 
IMRT  
1.5 
1C015 895.7 180 0 267.6 0.925 
1C015 883.6 5 0 375.5 1.172 
VMAT  
2 
1D020 895.7 180 0 270 1.007 
1D020 883.6 5 0 298.6 1.084 
 
Table 3.4− Plan Parameters applied for Thorax patient measurements 
Structure  
Energy  


















VMAT 0.5 SWA05 855 200 345 333.5 1.114 
SWB05 915.5 65 345 415 0.957 
VMAT  
1 
SWA10 855 200 345 301 0.961 
SWA10 915.5 65 345 378.9 1.105 
VMAT  
1.5 
SWA15 855 200 345 267.6 0.925 
SWA15 915.5 65 345 375.5 1.172 
VMAT  
2 
SWA20 855 200 345 270 1.007 

















3.2 Results and Discussion  
        The procedures under section (3.1) done by using specifications of LINAC Elekta 
Synergy Installed at Tomsk Regional Oncology Clinic and the results analyzed and 
discussed using gamma index analysis and DVH analysis for (%𝛾(2%, 2mm, TH =
10%) ≥ 95% gamma criterion and recalculated under gamma analysis for (%𝛾(3%,
3mm, TH = 20%) ≥ 95% were set for both 2D and 3D-Dose analysis for segment 
widths of 0.5 cm up 2cm for each structure. Through the measurements some differences 
were observed which related to the dose distribution in each segment width for each 
structure or Localization.  The results explained as follows. 
3.2.1 Results for the first Experiment  
The first experiment done under (%𝛾(2%, 2mm, TH = 10%) ≥ 95% gamma criterion. 
Observed that all plans planned in 2D- dose analysis, each localization had lower gamma 
passing rate than threshold gamma passing rate of 95% was set for both 6MV and 10MV 
photon beams on both structures as shown on the tables (4.1, 4.2 and 4.3) below.   
          The table 3.1 represented the EPID measured and calculated results of the lung 
plans at (%𝛾(2%, 2mm, TH = 10%) ≥ 95% gamma criterion when 6MV photon beam 
and IMRT modality of dose delivery were used.  For 05 x 12, 05 x 14, 10 x 11, 10 x 14, 
15 x 12 15 x 14, 20 x11, 20 x 12 and 20 x14 beam names, had  gamma passing rate  lower 
than mean calculated gamma passing rate of 60.57%,  although their dose difference 




































0.5 05 x11 67.79 0.471 0.468 -0.6 -0.3 
05 x12 60.95 0.616 0.626 1.6 1 
05 x13 67.12 0.397 0.390 -1.7 -0.7 
05 x 14 38.01 0.300 0.300 1.6 0.5 










1 10 x 11 57.85 0.476 0.524 10 4.8 
10 x 12 60.12 0.606 0.611 0.8 0.5 
10 x13 71.79 0.485 0.501 3.5 1.7 
10 x 14 43.01 0.237 0.233 -1.6 -0.4 




  19.54 




1.5 15 x 11 67.26 0.469 0.481 2.5 1.2 
15 x 12 57.41 0.538 0.548 1.8 1 
15 x 13 69.11 0.429 0.428 -0.2 -0.1 
15 x 14 49.65 0.283 0.272 -3.8 -1.1 









2 20 x 11 48.7 0.467 0.497 6.4 3.0 
20 x 12 48.49 0.503 0.508 0.9 0.5 
20 x 13 64.5 0.465 0.461 -0.8 -0.4 
20 x 14 45 0.307 0.303 -1.3 -0.4 




















            For 05 x 12, 05 x 14, 10 x 12, 10 x 14, 15 x 14, 20 x 12 and 20 x14 beams, had 
lower EPID dose difference than the mean dose difference but still had lower gamma 
passing rates than 60.57% and hence associated with under dose. Figure 3.1 showed the 
comparison the between the delivered dose and expected EPID portal dose image for the 
05 x 14 beams in 2D-dose distributions. The red color indicted the higher dose and blue 
color indicated the lower dose and green color indicated the gamma index.  The EPID 
measured portal dose imaged had large red spots than delivered image dose Expected. 
 
Fig 3.1.Comparison between the delivered dose and Expected portal dose image for 
2B010 beam for the Lung for plans (2%, 2mm, TH=10%) gamma criterion 
 
         The table 4.2 Represented the EPID measured and calculated results for the 
Prostate plans at (%𝛾(2%, 2mm, TH = 10%) ≥ 95% gamma criterion. All plans 
planned by IMRT and VMAT dose delivery technique, using 10MV photon beam.  0.5, 
1 and 2cm planned by VMAT and 1.5 cm planned by IMRT.   
               The results showed all beams had higher gamma passing rates than the mean 
gamma passing rate of 75.33 % except 2B010 and 2D020 beams had lower gamma 
passing rate than 75.33% and hence they associated slightly with under-dose. This was 
explained by the smaller value of EPID measured dose difference (-1% and 2.6%) than 
the mean calculated dose difference (-0.8%). So the higher negative values means that 
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the lower dose and thus why their passing rate were lower. The figure 3.2 showed the 
comparison the between the delivered dose and expected EPID portal dose image for 
2B010 beam in 2D-dose distributions. The EPID (expected) portal dose image  
associated with lower dose than the delivered dose image  this indicated by large area to 
be covered with blue spots. So if this beam will be used, tumor will be received lower 
dose than expected. 
 

















Energy   
SW 
(cm) 
Beam   Passed 
 Points 





























1a005 87.76 1.114 1.109 0.4 0.5 











1B010 90.30 0.961 0.950 1.1 1.1 











1C015 90.32 0.925 0.934 0.9 0.9 
2C015 76.99 1.172 1.152 -1.6 -1.9 
Mean 
±SD   
83.66 
10.81 






1D020 83.71 1.007 0.976 -3.0 -3.1 
2D020 72.32 1.084 1.055 -2.6 -2.9 
Mean 
±SD   
78.015 
9.23 















Fig 3.2.Comparison between the delivered dose and Expected portal dose image for 
2B010 beam for the prostate for plan (2%, 2mm, TH=10%) gamma criterion. 
           The table 4.3 represented the EPID measured and calculated results for the Thorax 
plans planned at (%𝛾(2%, 2mm, TH = 10%) ≥ 95% gamma criterion. All plans 
planned by VMAT dose delivery techniques using 6MV photon beam.  The results 
indicated that all beams had higher passing rate than mean calculated passing rate 
(75.68%) expect 1a005 beam which had lower gamma passing rate of 14.17%.  This 
explained by lower dose difference of 0.1% than mean calculated dose difference of 
3.14%. 
          Figure 4.3 showed the comparison the between the delivered dose and expected 
EPID portal dose image for 1a00 beam in 2D-dose analysis. The EPID (expected ) portal 
dose image  associated with lower dose than the delivered dose image  this indicated by 
large area to be covered with blue spots. So if this beam will be used, tumor will be 






Table 3.3−Thorax plan results   in 2D-dose analysis 
 












































1a005 14.17 0.979 0.980 0.1 0.1 











1B010 78.49 1.019 1.066 4.6 4.7 











1C015 78.85 1.019 1.030 1.0 1.1 











1D020 76.51 0.951 1.058 11.2 10.7 




















Fig 3.3. Comparison between the delivered dose and Expected portal dose image for 
1a005 beam for the thorax for plan (2%, 2mm, TH=10%) gamma criterion 
                DVHs analysis used to analyze the measured by EPID through PerFRACTION 
software of 3D-dose distributions by combining all the plan fields planned in 2D-dose 
distributions under   (2%, 2mm, TH=10%) gamma criterion when threshold gamma 
passing rate of 95% was set for both segment widths in each structure (localizations). 
The results showed that in some segment width in 3D- dose distributions satisfied  and 
some segment widths were not satisfied the (2%, 2mm, TH=10%) gamma criterion for 
threshold gamma passing rate of 95%  as shown on the table 3.4. below.  
         For lung, all plans planned using IMRT dose delivery technique using 6MV photon 
beam.  The mean gamma point passing rate for the lungs plans was 95.4% which was 
higher than threshold gamma passing rate of 95%.  0.5 cm and 1.5 cm segment widths 
had higher gamma point passing rate than 95.4%, the higher gamma point passing rate 
explained by lower iso-center composite dos difference of 0.4% and 1.2 % respectively 
measured by EPID which were less than the mean calculated dose difference of 1.65%. 
1 cm and 2 cm segment widths had lower gamma passing rates of 90.33% and 93.83% 
respectively which were lower than mean gamma passing rate of 95.4%. The lower 
gamma passing rate for 1cm segment width explained by large value of dose difference 
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of 3.8% which was higher than the mean dose difference and hence these segment 
associated with slight overdose to the OARs and slightly under-dose to the PTV. The 
lower gamma passing rate on 2 cm segment widths was explained by lower dose 
difference of 1.2% than 1.65% and hence this segment width associated with under-dose 
to the PTV. 
Table 3.5−Isocenter Composite point dose results under (2%, 2mm, TH=10%) gamma 
































0.5 1.837 1.845 0.4 0.8 99.39 
1 1.868 1.938 3.8 7 90.33 
1.5 1.827 1.849 1.2 2.2 98.06 
2 1.833 1.854 1.2 2.1 93.83 
Mean 
±SD 












0.5 2.071 2.06 -0.5 -1.1 88.42 
1 2.065 2.045 -1.0 -2.0 93.29 
1.5 2.098 2.041 -2.7 -5.7 94.36 
2 2.093 2.032 -2.9 -6 96.42 
Mean 
±SD 












0.5 2.19 2.155 1.2 2.6 92.45 
1 2.163 2.204 1.9 4.1 85.5 
1.5 2.163 2.165 0.1 0.2 84.47 
2 2.167 2.36 8.9 19.3 68.13 
Mean 
±SD 










Table 3.6- Results of the gamma passing rate for TPS and DVH analysis at (2%, 2mm, 
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        The quantitatively results of PTV and OARs are represented and analyzed as shown 
on the table 3.5 and table 3.6. According to the results from the table 3.5, there slight 
difference between the TPS gamma passing rate and per-fraction gamma passing rate, 
TPS gamma passing rate showed that only 1cm segment width had lower gamma passing 
rate than 89.25% and per-fraction showed that only 1cm segment width had lower 
gamma passing rate than 90.22%, so the results showed that at 1cm segment width PTV 
was irradiated with lower dose than other segment width and hence associated with large 
effect of reproducibility values. So at (2%, 2mm, TH=10%) gamma criterion only 0.5 








           Table 3.6 showed the results of the OARs, when PTV63 (lung) was irradiated 
with 6MV by using IMRT modality, the results showed that spinal cord at 1cm and 1.5 
cm segment had lower gamma passing rates than mean calculated gamma passing rate 
and hence associated with higher dose, the lower gamma passing rate in 1cm and 1.5 
segment width explained by large dose difference of 6.5% and 3.1% than the maximum 
tolerance dose difference of 2% used. For Total Lung GTV, 1cm segment width had 
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lower passing rate than other this means, it has associated with large reproducibility 
effect.   
           Tables 3.7 and 3.8 represented the results of the PTV and OARs when the prostate 
irradiated with 10MV. Table 3.7 showed that all segment width had lower gamma 
passing rate  than 95% used as reference this indicated that  PTV received (irradiated 
with) lower dose, this proved by TPS  and Per-fraction Gamma passing rates. The large 
reproducibility the lower gamma passing rate. Table 3.8 showed that for rectum   there 
are slightly difference between the TPS and Per-fraction gamma passing rates of 
(93.65±3)% and (96.5±1.73)%.  For bladder had (93.75±2.9) % and (96.6±1.62) % 
gamma passing rates. 
Table 3.7− TPS Gamma passing rate and DVH analysis at (2%, 2mm, TH=10%) 



















































































Table 3.8− Results of OARs for each segment width between 0.5cm and 2cm 
OARs S.W 
(cm) 










































































            Table 3.7 above showed the results of the thorax (PTV) when the Thorax irradiated 
with 6MV. From the results observed that the PTV was irradiated with lower dose, thus 
is why the gamma passing rates in each segment width were lower, the lower gamma 
passing rate indicated the effect of reproducibility, the large effect of reproducibility the 
smaller passing rate than the lower value of reproducibility . At 2cm segment width the 
PTV was irradiated by very low dose than other segment width. Although PTV irradiated 
with lower dose but there slightly difference between the TPS and Per-fraction gamma 
passing rates of (59.5±40.32) % and (59.41± 40) %.   
          Table 3.8 showed the results of OARs for each segment width when thorax 
irradiated with 6MV photon beam using VMAT, the results showed that the Total lung-
P at  0.5, 1  and 1.5 cm segment widths had large gamma passing rate than 79.25%  but 
at 2cm segment width , the Total Lung-P had lower gamma passing rate than  79.25%, 
this explained by large dose difference of 11.1% than 4.1%, but generally all segment 
associated with higher dose because they  had lower gamma passing rate than 95% 
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Table 3.9−Results of the GPR for TPS and DVH analysis at (2%, 2mm, TH=10%) 
gamma criteria at 𝐷𝑚𝑒𝑎𝑛,𝐷95 and 𝐷90 for Thorax target (PTV) 
 
Table 3.10−Measurements of OARs for each segment width between 0.5cm and 2cm 
OARs S.W 
(cm) 
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3.2.2 Results of the Second Experiment  
         The (%𝛾(3%, 3mm, TH = 20%) ≥ 95% gamma criterion was performed in the 
experiment in order to recalculate  or to check the results of the first experiment done by 
(%𝛾(2%, 2mm, TH = 20%) ≥ 95% gamma criterion for the same EPID and per-
fraction software under the same procedures for 2D-dose analysis.  The results as shown 
on the table below 3.11. The results indicated that, 2D-dose analysis due to (%𝛾(3%,
3mm, TH = 20%) ≥ 95% gamma criterion had good results for all plans in each 
structure compared to the (%𝛾(2%, 2mm, TH = 20%) ≥ 95% gamma criterion   when 
it is used. For the 3D-dose analysis both gamma criterion produced the same results in 
each segment for each structure or localization.  
         For the Lung plans, the gamma passing rate was improved from 60.57% ±19.3  in 
(%𝛾(2%, 2mm, TH = 10%)) ≥ 95% gamma criterion to gamma passing rate 
92.58% ± 6.41% in (%𝛾(3%, 3mm, TH = 20%)) ≥ 95% in 2D-dose analysis. 
             For the prostate plans. The gamma passing rate was improved from 75.33% 
±33.69%  in (%𝛾(2%, 2mm, TH = 10%)) ≥ 95% gamma criterion to gamma passing 
rate 91.69% ± 3.7% in (%𝛾(3%, 3mm, TH = 20%)) ≥ 95% in 2D-dose analysis but 
for the 3D-dose analysis both gamma criterion produced the same results in each segment 
width for each structure or localization.    For the thorax plans the gamma passing rate 
was improved from 75.64% ±25.64%  in (%𝛾(2%, 2mm, TH = 10%)) ≥ 95% gamma 
criterion to gamma passing rate 81.63% ± 12.52% in (%𝛾(3%, 3mm, TH = 20%)) ≥ 






Table 3.11− Results Lung, Prostate and Thorax plans for 6MV and 10MV for (%𝛾(2%,






 (2%, 2mm,  
TH=10% at 95%) 
%GP  
(3%, 3mm, 





















0.5 62.68 99.39 98.6 99.39 
1 61.2 90.33 85.4 90.33 
1.5 62.2 98.06 96.1 98.06 



















0.5 87.24 88.42 87.76 88.42 
1 52.42 93.29 90.30 93.29 
1.5 83.66 94.36 93.1 94.36 


















0.5 54.45 92.45 91.3 92.45 
1 82.64 85.5 84.4 85.5 
1.5 82.17 84.47 83.6 84.47 



















CHAPTER 4 : LITERATURE REVIEW 
        According to WHO (2020) the major causes of death in worldwide is cancer  and it 
is characterized by uncontrolled growth and spread of abnormal cells and expected that 
the number of new cancer cases will be increased by 70% to more than 22million cases 
in twenty years from now. According to international   Agency of research on cancer 
(IARC-2018), large than 43% of all new cases in the worldwide come from the following 
group of cancer: Lung, Female breast, intestines plus anus and Prostate cancers. 
            Due to the source of radiation, Internal and External Radiotherapy can be 
distinguished. Internal Radiotherapy uses radioactive sources placed on the surface or 
inside of the patient in a very close location of the tumor. High-energy photons (X-ray 
and γ-ray) and electrons, produced by a linear accelerator (LINAC) are among of 
ionizing radiation used in EBRT according to Podgorsak. E. (2005). According to 
Nijsten. S (2009). The beam high energy x-ray photons modulated and shaped before 
moving outside the treatment head of the LINAC. Beam may be shaped either by 
moulded blocks or MLC or jaws that are installed in the machine. The MLC typically 
consists of a series of 80 to 160 movable metallic leaves arranged in pairs. By changing 
their individual position, these leaves can block some part of the intensity of the beam 
thereby shaping the gape due to the tumor shape. 
          Tumor volumes, OARs and other atomic structure are the essential part in the 
radiotherapy treatment planning process for optimal treatment’ ICU reports 50, (1993,). 
These contain clear definitions to enable centers to use the same criteria for delineating 
tumors for radiation so that their treatment results can be compared. 
           According to Jordan and Williams (1994) multi-leaf collimators have many 
functions in radiation therapy. MLC defines the exchange of conventional radiotherapy 
blocks which decreeing the duration needed by removing the block production   and also 
decrease he duration of sequential field setting but at the same time in associated with 
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challenges. LoSasso, Chui, and Ling (2001) improving the technology allows the using 
of IMRT techniques  which leaves  of MLC  can be either used in manner out than 
expected and QA is required  to verify the accurate leaf location  and leaf function. 
             Yu. C (1955) and Otto.K (2008) MLC deliver more conformal distributed dose 
in 3D when beam dynamically modulated either by continuous shaping of the dose rate 
and changing of the gantry velocity compared conformal 3D-distributed dose generated 
under fixed gantry. VMAT needs small number of monitor unit and generally used 
shorter duration to obtained distrusted dose according to Otto. K(2008, 2010) and  to 
Goyal and Kataria (2014) and  Van Herk (2004) in radiotherapy terms a treatment error 
can be defined as any deviation in treatment delivery from what as planned or intended 
to be delivered.   
           Incorrect leaves positions can destroy distributed dose at any point in the surface 
which differentiated conventional blocking from MLC. In sliding window of MLC, an 
uncertainties in position of the leaf can be taken through entire field, causing the red 
spots when leaves closed and blue spots when the leaves opened, Chui, Spirou, and 
LoSasso (1996). Red and blue also can be appeared during the step and shoot deliveries 
to regions of many sub-field structures. Red and Blue spots indicated the significance of 
function of the leaf position assurance of MLC during the clinical dose delivering by 
static or dynamic IMRT mode 
               TG142 divides MLC-equipped Linacs into three types; these are non-IMRT, 
IMRT and those capable of MLC or micro-MLC-based Stereotactic 
radiosurgery/Stereotactic body radiation therapy, with each type requiring different 
procedures and tolerances on these procedures. The Canadian Partnership for Quality 
Radiotherapy (CPQR) replaced CAPCA to generate, maintain and inform the QC and 
QA systems. In 2013, CPQR released ‘Technical Quality Control Guidelines for 
Canadian Radiation Treatment Centres: Medical Linear Accelerators and Multileaf 
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Collimators’ which summarized and combined the 2005 and 2006 CAPCA documents. 
The TG142 and CPQR documents includes Linac and MLC QC and specifies that it is 
for non-patient specific IMRT QA.  
        According to Ping X., Joseph Y. T, Colin G. O (2007). Dynamic multi-leaf 
collimation where the collimator leaves are moving while beam is ON and hence the 
velocity of the leaves of the leaves is virtually important. This makes DMLC more 
complicated to plan and deliver than MLC.  According to LoSasso, Chui, Ling (1998), 
leaf gap separation defines the broadening of the radiation field than narrow field of the 
grooved MLC leaf edges. The dosimetric leaf gap can be estimated the dose method 
using sweeping gaps of various widths. A tolerance of 0.1 mm is advised. 
           According to McDermott, L. N (2007), Electronic portal imaging devices were 
originally developed for verification of patient positioning during treatment and to 
replace film that was previously used. The images of the megavoltage treatment beam 
acquired by the EPID, also called portal images, used to estimate the discrepancies in the 
patient set-up or errors of the radiation field placement prior or during field delivery. Set-
up verification measurements of the patient position, it was realized that EPID images 
also contained dose information.   According to Van Elmpt et al. (2008) EPIDs used as 
devices for transmission (transit), or non-transmission (non-transit) dosimetry, i.e., with 
or without an attenuation object. Pre-treatment verification can detect a large number of 
errors in the radiotherapy chain before starting treatment, but if there is any unexpected 
change during the treatment time, it will be missed. It is not easy to translate the influence 
of pre-treatment discrepancies on the real dose distribution delivered at the day of 
occurrence.  Possible sources of errors could be changes in the linac output, incorrect 
accessory, MLC failure, patient changes (tumor shrinkage, weight loss, organ motion, 
anatomical changes in patient since planning CT) or even changes in patient setup, 
including obstruction from immobilization devices (van Elmpt et al., 2008; Chytyk-
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Praznik et al., 2013). Many of these errors could be detected if all parameters would be 
checked during the patient treatment via patient transmitted dose.  
            According (Low et al., 2011; Mijnheer et al., 2013) in vivo dosimetry (IVD), as 
part of a QA program, could detect major errors and indicate the relevance between 
treatment’s planned and treatment’s delivered.  Comprehensive overviews of techniques 
of IMRT/VMAT testing by using point detectors, two-dimension arrays, films, and also 
EPIDs. The EPID is an excellent in vivo dosimetry system since performed dose 
verification in all dimensions (0, 1, 2, 3 and 4D).    Both methods can be categorized into 
a forward and back-projection or dose reconstruction approach. In the forward approach, 
the verification of fluence or dose is done at the position of the imager, while in the 
second approach measurements are made outside the attenuating medium, and the 
verification is performed inside the patient or phantom (Wendling et al., 2006; Wendling 
et al., 2009). There are different possible approaches to using portal dose information for 
verification. McCurdy and Pistorius (2000) comparison of the measured portal dose 
image (PDI) to a predicted image. This in turn could be done either in vivo with a PDI 
of the patient in position compared to a predicted image calculated using CT data of the 
patient, or with a PDI of the radiation field without patient compared to a predicted image 
calculated without patient (Van Esch et al., 2004).  
         According to Kasper. L. Pasma (1999) a method of pre-treatment verification used 
to ascertain that the radiation fluence is delivered from the accelerator in accordance with 
the plan. This method would reveal errors in the movement and positioning of the MLC 
leaves, the correct transfer of the treatment plan and the mechanical and dosimetric 
performance of the accelerator. Pre-treatment testing of this kind mainly occurs in 
intensity modulated radiotherapy (IMRT) where the high complexity, with changing leaf 
patterns and non-homogenous dose distributions, increases the risk of errors as well as 
making the errors more difficult to detect. 
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      According to Zhuang A. and Olch A. (2015) per-fraction from Sun Nuclear 
(www.sunnuclear.com) compares EPID images from each field of each fraction n (>1) 
behind a patient with a reference portal image using 2D gamma analysis. In a sensitivity 
study of this software, it was demonstrated that per-fraction, using integrated EPID 
images, is sensitive enough to identify positional, angular, and dosimetric errors. The 
EPID image applied to evaluate MLC leaf positions of that fraction that applied as input 
for a 3D dose calculation on planning CT data using the linac log-file. Such an approach 
should be considered as a pseudo-3D dose verification tool but not as an in vivo 
dosimetry method.  The per-fraction Fraction 0 software from Sun Nuclear 
(www.sunnuclear.com) is also able to perform a 2D dose determination at  EPID surface, 
and then compared to the distributed dose in that plane calculated with the TPS for 
independent 2D planar analysis. The EPID image also applied to evaluate MLC leaf 
position applied as input for a 3D dose calculation on planning CT data using the linac 
log-file.  
         According to Low D. A. et.al (1998) gamma evaluation technique used 
quantitatively method to compare distributed dose, including superimposed isodoses, 
dose-difference, and distance-to-agreement (DTA) distributions. The criterion for 
acceptable calculation performance is generally defined as a tolerance of the dose and 
DTA in regions of low and high dose gradients, respectively. The dose difference and 
DTA distributions complement each other in their useful regions. A composite 
distribution has recently been developed that presents the dose difference in regions that 
fail both dose-difference and DTA comparison criteria.  By approaches developed by  
Podesta. M,   Persoon L. C. G. G,   Verhaegen. F. A (2014), the acceptance criteria are 
applied. The pixels or voxels for which |𝛾|≤ 1 meet the acceptance criteria and are 
considered to pass the gamma analysis. The pixels or voxels for which |𝛾|≥ 1 are not 
satisfy the acceptance criteria and are considered to fail the gamma analysis. 
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CHAPTER 5 : FINANCIAL MANAGEMENT, RESOURCE EFFICIENCY AND 
RESOURCE SAVING 
5.1 Pre-Research Analysis  
         The research evaluates the Multi-leaf Collimator (MLC) Parameters 
Reproducibility of Intensity Modulated Radiotherapy (IMRT) and Volumetric 
modulated arc Therapy (VMAT). This master’s thesis performed on clinical base in 
Tomsk Regional Oncology Clinic. This research was done by special equipment, Elekta 
Synergy Linear accelerator with equipped a-Si-EPID panel (iView-GT and XVI) system 
for Portal dose image calculation and Reproducibility detection. 
        Financial management, Resource efficiency and Resource saving are an important 
aspect in fulfil  a project, because they  help to measure the prospects and success of a 
Research Project plan  for managing and acquiring special support for implementation. 
It involves assessing the commercial potential, attractiveness to the target audience. This 
section discusses the issues of Competitiveness, Resource Efficiency and Resource 
saving, SWOT analysis as well as financial costs regarding the object of study of Master's 
thesis.  
        Competitiveness analysis is carried out for this purpose. SWOT analysis helps to 
identify strengths, weaknesses, opportunities and threats associated with the project, and 
gives an idea of working with them in each particular case. In-order to achieve the goals 
of my thesis, fund was required to pay as the salaries for participants or assistant of my 
project and also fund required for necessary equipment, a complete list is given in the 
relevant section. The calculation of the resource efficiency indicator helps to make a final 
assessment of the technical decision on individual criteria and in general. 
        Nowadays, nuclear medicine has a wide range of technologies and has sophisticated 
equipment for diagnosis and treatment of cancer. Radiotherapy is the most effective 
method for a cancer treatment, compared with surgery or chemotherapy.  Modern 
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radiotherapy allows to escalate the dose to the tumor and minimize the dose to the healthy 
tissues. The realization of such state-of-the-art technologies requires high accuracy in 
performing. In this study the effectiveness of IMRT and VMAT quality assurance of 
MLC parameters and their impact Reproducibility on treatment planning has been 
evaluated. The study used in medicine but based treatment planning and quality 
assurance of radiotherapy in treatment of malignant tumor. The final consumer is 
radiotherapy departments. Studies have shown advantage of the treatment planning of 
IMRT and VMAT for Lung, Prostate and Thorax cancer. 
5.1.1 Competitiveness Analysis of Technical Solutions 
The evaluation of the commercial value of work, helping to find the source of financing 
of the project. Analysis of competitive technical solutions in terms of resource efficiency 
and resource saving allows to evaluate the comparative effectiveness of scientific 
development. The evaluation card was used to carry out of this analysis. 
First of all, it is necessary to analyze possible technical solutions and to select the 
best one based on the consideration of technical and economic criteria. 
 Evaluation map analysis presented in Table 5.1. As the competitive methods are 
chosen IMRT (C1), VMAT (C2) and Non-Usable (C3) modality for MLC parameters. 
These modalities are evaluated with the five-point scale for each chosen criterion, where 
1 is the weakest position and 5 is the strongest. The weights of indicators in the amount 
should be 1. Analysis of competitive technical solutions is determined by the formula 
10: 
 
                                    𝐶 = ∑ 𝑊𝑖
𝑚
𝑖=1 ∗  𝑃𝑖                                           (10) 
 
С - the competitiveness of research or a competitor; 
Wi– criterion weight; 
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Pi – point of i-th criteria. 
Table 5.1 – Evaluation Card for Comparison of Competitive Technical Solutions 






P2 P3 C1 C2 C3 
1 2 3 4 5 6 7 8 
Technical criteria for evaluating resource efficiency 
Planning efficiency  0.1 5 4 3 0.5 0.3 0.4 
Energy efficiency  0.1.5 3 4 5 0.75 1.25 0.2 
3. Delivery dose  0.05 4 3 2 0.2 0.1 0.1 
4. Delivery time  0.05 5 4 4 0.5 0.6 
0.0
5 
5. Dose conformity  0.1 4 3 3 0.4 0.5 0.3 
5. Reliability of results   0.05 4 3 4 0.3 0.4 0.3 
4. Functional Capacity  0.1 3 4 5 0.3 0.5 0.4 
5. Labor Intensity   0.1 5 4 3 0.8 0.9 0.8 
6. Ease of use  0.1 5 3 4 0.5 0.4 0.3 
Economic criteria for performance evaluation  
1. Competitive ability  0.05 4 4 5 0.4 0.25 0.1
5 
2. Wide accepted 
method  
0.05 2 2 4 0.15 0.25 0.1
5 
3. Expected life cycle  0.1 5 5 5 0.5 0.5 0.5 
        Total  1    5.4 5.95 3.6
5 
 
The results showed, VMAT had good score because of the reliability of the 
results, is the most competitive, due to the dose delivery, dose conformity and time 
delivery, is very similar to IMRT, but Non-useable modality had bad results and has less 
dose conformity than IMRT modality. 
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5.1.2 SWOT Analysis 
Complex analysis solution with the greatest competitiveness is carried out with 
the method of the SWOT analysis: Strengths, Weaknesses, Opportunities and Threats. 
The analysis has several steps. The first step consists the strengths and weaknesses of the 
project, identifying opportunities and threats to the project that have emerged or may 
appear in its external environment. The second stage consists of identifying the 
compatibility of the strengths and weaknesses of the project with the external 
environmental conditions. This compatibility or incompatibility should help to identify 
what strategic changes are needed. SWOT analysis of this study as shown on the table 
5.2 
Table 5.2 – SWOT analysis 
 Strengths: 
S1. Increasing of 
dose distribution 
accuracy  
S2. Development of 
single approach 
based on clinical 
reality and aims 
Weaknesses: 
W1. Lack of equipment 
W2. Lack of staff 
expertise 
Opportunities: 
O1. Time management 
planning  
O2. Reduction of dose 
delivered  
to the healthy tissues or organ 
at risk 
Strategy which 













trainings allow to 
improve the accuracy of  












2)Competent approach would allow to 
use equipment according to aims 
Threats: 
T1. Threat of  
MV injury 





Strategy which based 


























Strategy which based on strengths and 
threats: 
1) Regular courses of medical staff 
increase the level of education, 
which potentially raise interest to 
new technologies 
2) Getting research grants 
 
5.2 Project Initiation 
The initiation process group includes the processes that are performed to define 
a new project or a new phase of an existing one. In the initiation processes, the initial 
purpose and content are determined and the initial financial resources are fixed. The 
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internal and external stakeholders of the project who will interact and influence the 
overall result of the research project are determined (table 5.3 and 5.4). 
 
Table 5.3 – Stakeholders of the Project 
Project stakeholders Stakeholder expectations 
Clinical departments Research of advantages comparison of 




Table 5.4 – Purpose and results of the project 
Purpose of 
project: 
- To evaluate the multi-leaf parameters Reproducibility 
of IMRT/VAMT plans. 
Expected 
results of the 
project: 
- Comparison of reproducibility in each MLC 
parameters for a group of patients. 
- Evaluation of under-dose in PTV and overdose in 
OARs.  
- Finding the best segment width which we can be used 
for treatment planning. 
- Finding the relationship between the MLC parameters 





- Increasing of effectiveness of treatment up to 95% of 
patient receiving 95% of prescribed dose in PTV. 
Requirements 
for the project 
results  
- The project should be finished to the 1st of June 
- The results  of the project should  be meet the criteria for 
acceptance  
- The results of this research must be demonstrated at 
Russian conference  
- In case of unacceptable results it is important to repeat 




5.2.1 The organizational structure of the project 
It is necessary to solve some questions: who will be part of the working group of 
this project, determine the role of each participant in this project, and prescribe the 
functions of the participants and their number of labor hours in the project. This 
information is collected in table 5.5. 
Table 5.5 – The working group of the project 
№  Participant  







E.S. Sukhikh, PhD, 
Chief Medical 








2 A.V.Vertinsky  
Assistant 








3 E.J .Chuma 
Master 
student 









5.2.2 Project Limitations  
Project limitation are all factors that can be as a restriction on the degree of 





Table 5.6 – Project limitations. 
Factors Limitations / Assumptions 
Project's budget 20650000 of rubles 
Source of financing Government budget 
Project timeline: October 2020-June 2021 
Date of approval of plan of project 01.02.2021 
Completion date 01.06.2021 
 
5.2.3 Project Schedule 
Also as a part of planning a science project, it is necessary to build a project 
timeline and a Gantt chart (tab5.7 and 5.8). 










1  Creation and Approving 
Technical Specification  
5 01.20.2021 05.02.2021 
Research  
Supervisor  
2 Finding and  Studying of 
Literature Review 




Selection study way  2 18.02.  2021 19.02 .2021 
Research 
supervisor  
4 Experiment and measurements 
performing  




Development of general 
methodology of the research 





6 Calendar planning of research 
activities 




 Analysis, description of the 
Results and writing of thesis 





8 Compilation of the master’s 
thesis 





            A Gantt chart, or harmono-gram, is a type of bar chart that illustrates a project 
schedule table5.7. This chart lists the tasks to be performed on the vertical axis, and time 
intervals on the horizontal axis. The width of the horizontal bars in the graph shows the 
duration of each activity.  
Table 5.7 – Calendar schedule of master’s thesis performing 
№ Activities  Participants 
Тc, 
days 
Duration of the project 
February  March  April May 








           
2 






           
3 
Creation of 





RS 2   
 






performing    
 MS 35     
 






RS, MS 7       
 






RS 2        
 




Continuation of table 5.7. Calendar schedule of master’s thesis performing 
7 
Analysis, 
description of the 
Results and 
writing of thesis 







MS 20            
 
Icons show participations activity,    -master’s student,        - Research Supervisor. 
5.3 Scientific and Technical Research budget 
The amount of costs associated with the implementation of this work is the basis 
for the formation of the project budget. This budget will be presented as the lower limit 
of project costs when forming a contract with the customer. 
To form the final cost value, all calculated costs for individual items related to 
the manager and the student are summed. 
In the process of budgeting, the following grouping of costs by items is used: 
 Material costs of scientific and technical research; 
 Costs of special equipment for scientific work (Depreciation of equipment used 
for design); 
 Basic salary; 
 Additional salary; 









The budget for scientific and technical research is shown in table 5.8. 




















 20104000 71070 7107 56899 140463 20360740 
5.3.1 Calculation of material costs 
The calculation of material costs is carried out according to the formula: 
𝐶𝑛𝑇 = (1 + 𝑘𝑖) × ∑ 𝑃 × 𝑁𝑐𝑜𝑛𝑠𝑡
𝑛
𝑖=1   (11) 
Where n – the number of types of material resources consumed in the 
performance of scientific research; Nconsi – the amount of material resources of the i-th 
species planned to be used when performing scientific research (units, kg, m, m2, etc.); 
Pi – the acquisition price of a unit of the i-th type of material resources consumed (rub. 
/units, rub. /kg, rub. /m, rub. /m2, etc.); kТ – coefficient taking into account transportation 
costs. 
Prices for material resources can be set according to data posted on relevant 
websites on the Internet by manufacturers (or supplier organizations). 
Table 5.9 – Material costs. 
№ Name Units Amount 




1 Internet  GB 20 5000 5000 
2 Paper  Bundle  1 350 350 
3 Electrical cables  20A 2 800 800 
4  Pen  Black/Blue 50 50 2500 
5 Computer  Lenovo   1 30000 30000 
Total 38650 
       For this kind of work some equipment have been already bought. So we need to 








, where D – annual deprecation; Cprimary – primary cost of equipment; Nd=100/Tlife – 
norms of depreciation deductions, Tlife – service life of equipment. It is supposed, that 
service life of all equipment is 10 years. 
Table 5.10 – Special equipment. 








Synergy   
 









Elekta  1 14340 14.340 
Total 20014.34 
5.3.2 Basic salary 
This point includes the basic salary of participants directly involved in the 
implementation of work on this research, research advisor am master’s student. The 
value of salary costs is determined based on the labor intensity of the work performed 
and the current salary system. 
The basic salary (Sb) is calculated according to the following formula: 
𝑆𝑏 = 𝑆𝑎 × 𝑇𝑤 (13) 
Where Sb – basic salary per participant; Тw – the duration of the work performed 
by the scientific and technical worker, working days; 







Where  Sm – monthly salary of an participant, rub; М – the number of months 
of work without leave during the year: at holiday in 49 days, M = 10.4months, 5 days 
per week; Fv– valid annual fund of working time of scientific and technical personnel 
(251 days). 
 
Table 5.11 – The valid annual fund of working time 
Working time indicators Participants 
Calendar number of days 365 






Loss of working time 
- vacation 




The valid annual fund of working time 242 
 
Monthly salary is calculated by formula: 
𝑆𝑚𝑜𝑛𝑡ℎ = 𝑆𝑏𝑎𝑠𝑒 × (𝑘𝑝𝑟𝑒𝑚𝑖𝑢𝑚 + 𝑘𝑏𝑜𝑛𝑢𝑠) × 𝑘𝑟𝑒𝑔  (15) 
Where  
             Sbase – base salary, rubles; 
           kpremium – premium rate; 
             kbonus – bonus rate; 


























1.1 1.1 1.3 
64350 2369 30 71070 
Master’s 
student 
20000 57200 1861 76 141436 
 
5.3.3 Additional salary. 
This point includes the amount of payments stipulated by the legislation on labor, 
for example, payment of regular and additional holidays; payment of time associated 
with state and public duties; payment for work experience, etc. 
Additional salaries are calculated on the basis of 10-15% of the base salary of 
workers: 
𝑊𝑎𝑑𝑑 = 𝑘𝑒𝑥𝑡𝑟𝑎 × 𝑊𝑏𝑎𝑠𝑒 (16) 
Where Wadd – additional salary, rubles; 
kextra – additional salary coefficient (10%);  
Wbase – base salary, rubles. 
Table 5.13_Additional salary for 10% of the basic salary 
Performers  Research 
supervisor  
Master’s student   Total amount  
Base salary, 
rubles 
71070 141436 212506 
Additional 
salary, rubles 






5.3.4 Labor tax 
Tax to extra-budgetary funds is compulsory according to the norms established 
by the legislation of the Russian Federation to the state social insurance (SIF), pension 
fund (PF) and medical insurance (FCMIF) from the costs of workers. 
Payment to extra-budgetary funds is determined of the formula:  
𝑃𝑠𝑜𝑐𝑖𝑎𝑙 = 𝑘𝑏(𝑊𝑏𝑎𝑠𝑒 + 𝑊𝑎𝑑𝑑) (17) 
 
Where kb – coefficient of deductions for labor tax. 
In accordance with the Federal law of July 24, 2009 No. 212-FL, the amount of 
insurance contributions is set at 30%. Institutions conducting educational and scientific 
activities have rate - 27.1%. 
 
Table 5.14 – Labor tax for deduction of 30% 
Performer  Research supervisor Master’s student 
Total 
Base Salary, rubles 71070 141436 
Labor tax, rubles 23453.1 42431 65884.1 
 
5.3.5 Overhead costs. 
Overhead costs include other management and maintenance costs that can be 
allocated directly to the project. In addition, this includes expenses for the maintenance, 
operation and repair of equipment, production tools and equipment, buildings, structures, 
etc. 
Overhead costs account from 30% to 90% of the amount of base and additional 
salary of employees. 
Overhead is calculated according to the formula: 
𝐶𝑜𝑣 = 𝑘𝑜𝑣 × (𝑊𝑏𝑎𝑠𝑒 + 𝑊𝑎𝑑𝑑) (18) 
Where kov – overhead rate. 
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Table 5.14 – Overhead costs 




Overhead rate 70% 
Salary, rubles 71070 141436 
Overhead, rubles 54723 108905.72 163628.72 
5.3.6 Other direct cost 
PC work duration for this research is about 800 hours, linac measurement 
duration is 6 hours. Energy costs which include equipment and computer work are 
calculated by the formula: 
𝐶 = 𝑃𝑒𝑙 × 𝑃 × 𝐹𝑒𝑞 = 5.8 × (50kW × 6hours + 0.75kW × 800hours) = 5220 (19) 
Where Pel− power rates (5.8 rubles per 1 kWh); P − power of equipment, kW; 
Feq− equipment usage time, hours. 
5.3.7 Formation of budget costs 
The calculated cost of research is the basis for budgeting project costs. 
Determining the budget for the scientific research is given in the table 5.15. 
Table 5.15 – Items expenses grouping 
Name Cost, rubles 
1. Equipment deprecation 20014340 
2. Material costs 38650 
3. Basic salary 212506 
4. Additional salary 21250.6 
5. Labor tax 65884.1 
6. Overhead 163628.72 
7. Other direct cost 5 220 





5.4 Evaluation of the comparative effectiveness of the project 
Determination of efficiency is based on the calculation of the integral indicator of 
the efficiency of scientific research. Its finding is associated with the determination of 
two weighted averages: financial efficiency and resource efficiency. 
An integral indicator of the financial efficiency of a scientific research is obtained 
in assessing the budget of costs of three (or more) variants of the implementation of a 
scientific research as shown on Table 5. For this, the largest integral indicator of the 
implementation of a technical problem is taken as the basis of the calculation (as the 
denominator), with which the financial values for all execution options are correlated. 










– Integral financial indicator of current project; 
- 𝐹𝑝𝑖 – Price for i-th variant of execution;  
- 𝐹𝑚𝑎𝑥 – Maximum cost of execution of a research project (including analogs). 
The resulting value of the integral financial indicator of development reflects the 
corresponding numerical increase in the budget of development costs in times (a value 
greater than one), or the corresponding numerical reduction in the cost of development 
in times (a value less than one, but higher than zero). 
 The integral indicator of the resource efficiency of the variants of the object of 
research can be defined as follows: 





𝑎 −is an integral indicator of resource efficiency of options; 




 - the score of the i-th parameter for the analog and development, set by an 
expert method on the selected rating scale; 
- n - the number of comparison parameters. 























0.15 4 2 
3 
Noise level 0.15 5 3 2 
Energy efficiency 0.1 4 3 3 
Reliability 0.1 4 4 3 
Material consumption 0.15 4 3 3 
Safety  0.15 5 2 2 
Total 1   1 
 
                   𝐼𝑆𝑅𝑃 = 0.2 *5 + 0.15 * 4 + 5 *0.15 +0.1*4 +0.1*4 +0.15*4 + 0.15 *5=4.5 
      Analog1 = 3*0.2+2*0.15+3*0.15+3*0.1+4*0.1+3*0.15+2*0.1= 2.8 
        Analog 2 = 4*0.2+0.15*3+0.15*2+3*0.1+3*0.15+3*+2*0.15= 2.9 
An integral efficiency indicator of the scientific research project (𝐼𝑓𝑖𝑛
𝑃 ) and of the 
analog (𝐼𝑓𝑖𝑛
𝑎 ) are found according to the formula of the integral basis of the financial 
integral resource efficiency: 
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𝑎                                           (21) 
        The comparative efficiency the project will be determined by comparison of the 
integral indicator of the efficiency of the current project and analogs. Comparative 
project efficiency:        




𝑎                                                              (23) 
Where  
- 𝐸𝑎𝑣 is the comparative project efficiency;  
-  𝐼𝑓𝑖𝑛
𝑃  - Integral indicator of project;  
- 𝐼𝑓𝑖𝑛
𝑎 −Iintegral indicator of the analog. 
Table 5.17 −comperative Project efficiency 
№ Indicator Project Analog comparative 
project 
efficiency 
1 Integral financial indicator 1 1 1 
2 Integral resource efficiency 
indicator 
4.5 5.7 0.79 
3 Integral efficiency indicator 4.5 5.7 0.79 
 
               Comparison of the values of integral performance indicators allows us to 
understand and choose a more effective solution to the technical problem from the 





CHAPTER 6 : SOCIAL RESPONSIBILITY 
6.1 Introduction 
          Intensity Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc 
Therapy (VMAT) among of the Conformal Techniques used to deliver more conformal 
and high precise and accuracy dose to the tumor and minimizing the dose to the Organ 
at risk (OARs) or other health tissues. The evaluation of MLC parameters 
Reproducibility of IMRT/VMAT plans was estimated according to International 
protocols. Such procedures help to increase the maximum dose delivering to the target 
or Tumor (PTV) and to minimize the dose delivering to Organ at risks or healthy tissues. 
Experimental calculations have been performed to compare the Planned and Measured 
Measurements. These measurements allow to find the best segment width which we can 
use to provide optimal treatment planning. The research was performed by using Elekta 
Synergy Linear accelerator Installed at Tomsk Regional Oncology Clinic. 
        This work can be applied in radiotherapy department in area of Treatment planning 
and quality assurance in order to assure the dose delivered to the Target is optimal dose. 
6.2  Legal and organizational items in providing safety 
          Nowadays one of the main way to radical improvement of all prophylactic work 
referred to reduce Total Incidents Rate and occupational morbidity is the widespread 
implementation of an integrated Occupational Safety and Health management system. 
That means combining isolated activities into a single system of targeted actions at all 
levels and stages of the production process. 
            Occupational safety is a system of legislative, socio-economic, organizational, 
technological, hygienic and therapeutic and prophylactic measures and tools that ensure 
the safety, preservation of health and human performance in the work process [49]. 
According to the Labor Code of the Russian Federation, every employee has the right: 
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 to have a workplace that meets Occupational safety requirements; 
 to have a compulsory social insurance against accidents at manufacturing and 
occupational diseases; 
 to receive reliable information from the employer, relevant government bodies 
and public organizations on conditions and Occupational safety at the 
workplace, about the existing risk of damage to health, as well as measures to 
protect against harmful and (or) hazardous factors; to refuse carrying out work 
in case of danger to his life and health due to violation of Occupational safety 
requirements; 
 be provided with personal and collective protective equipment in compliance 
with Occupational safety requirements at the expense of the employer; 
 for training in safe work methods and techniques at the expense of the 
employer; 
 for personal participation or participation through their representatives in 
consideration of issues related to ensuring safe working conditions in his 
workplace, and in the investigation of the accident with him at work or 
occupational disease; 
 for extraordinary medical examination in accordance with medical 
recommendations with preservation of his place of work (position) and 
secondary earnings during the passage of the specified medical examination; 
 for warranties and compensation established in accordance with this Code, 
collective agreement, agreement, local regulatory an act, an employment 
contract, if he is engaged in work with harmful and (or) hazardous working 
conditions. 
The labor code of the Russian Federation states that normal working hours may not 
exceed 40 hours per week, the employer must keep track of the time worked by each 
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employee. Rules for labor protection and safety measures are introduced in order to 
prevent accidents, ensure safe working conditions for workers and are mandatory for 
workers, managers, engineers and technicians. 
6.3 Basic ergonomic requirements for the correct location and arrangement of 
researcher’s workplace 
The workplace when working with a PC should be at least 6 square meters. The legroom 
should correspond to the following parameters: the legroom height is at least 600 mm, 
the seat distance to the lower edge of the working surface is at least 150 mm, and the seat 
height is 420 mm. It is worth noting that the height of the table should depend on the 
growth of the operator. 
        The following requirements are also provided for the organization of the workplace 
of the PC user: The design of the working chair should ensure the maintenance of a 
rational working posture while working on the PC and allow the posture to be changed 
in order to reduce the static tension of the neck and shoulder muscles and back to prevent 
the development of fatigue.  
       The type of working chair should be selected taking into account the growth of the 
user, the nature and duration of work with the PC. The working chair should be lifting 
and swivel, adjustable in height and angle of inclination of the seat and back, as well as 
the distance of the back from the front edge of the seat, while the adjustment of each 
parameter should be independent, easy to carry out and have a secure fit. 
6.4 Occupational safety 
         A dangerous factor or industrial hazard is a factor whose impact under certain 
conditions leads to trauma or other sudden, severe deterioration of health of the worker 
[49]. A harmful factor or industrial health hazard is a factor, the effect of which on a 
worker under certain conditions leads to a disease or a decrease in working capacity. 
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6.4.1 Analysis of harmful and dangerous factors that can create object of 
investigation 
          The object of investigation is Intensity modulated radiotherapy (IMRT) and 
volumetric modulated arc therapy (VMAT) plans to carry out the evaluation of 
reproducibility of multi-leaf collimator parameters. Therefore, object of investigation 
can cause the harmful factor due to external irradiation of high-energy X-ray beam up to 
10 MeV, which can potentially causes acute radiation syndrome to the patients and 
radiation workers as well as stochastic effect of radiation workers due to prolonged 
exposure during work. 
6.4.2 Analysis of harmful and dangerous factors that can arise at workplace 
during investigation 
          The working conditions in the workplace are characterized by the presence of 
hazardous and harmful factors, which are classified by groups of elements: physical, 
chemical, biological, psychophysiological. The main elements of the production process 
that form dangerous and harmful factors are presented in Table 6.1. 













2. Excessive noise   + + 
3.Increased level of 
electromagnetic 
radiation 
+ + + 
4.Insufficient 
illumination of the 
working area 
  + + 
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Continuation of the Table 6.1 – Possible hazardous and harmful factors 
 
 
   
of residential and public buildings. 
Sanitary rules 2.2.4 / 2.1.8.562–96. 
Noise at workplaces, in premises of 
residential, public buildings and in the 
construction area. 
Sanitary rules 2.2.4.548–96. Hygienic 
requirements for the microclimate of 
industrial premises. 
5. Abnormally high 
voltage value in the 
circuit, the closure 
which may occur 
through the human 
body 
+ + + 
Sanitary rules GOST 12.1.038-82 
SSBT. Electrical safety. Maximum 
permissible levels of touch voltages 
and currents. 
6. Increased levels of 
ionizing radiation 
+ + + 
Sanitary Rules 2.6.1. 2523 -0 9. 
Radiation Safety Standards (NRB-
99/2009).  
 
The following factors effect on person working on a computer: 
 Physical factors :  
 Temperature and humidity;  
 Noise;  
 Static electricity;  
 Electromagnetic field of low purity; 
 Illumination; 
 Presence of radiation; 
 
 Psychophysiological factors: 
 Psychophysiological dangerous and harmful factors are divided into:  
 Physical overload (static, dynamic)  
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 Mental stress (mental overstrain, monotony of work, emotional 
overload) 
 Deviation of microclimate indicators 
           The air of the working area (microclimate) is determined by the following 
parameters: temperature, relative humidity, air speed. The optimum and permissible 
values of the microclimate characteristics are established in accordance with [34] and 
shown on Table 6.2 
Table 6.2 - Optimal and permissible parameters of the microclimate 





Speed of air 
movement, m/s 
Cold and changing of 
seasons 
23-25 40-60 0.1 
Warm 23-25 40 0.1 
 Excessive noise 
         Noise and vibration worsen working conditions, have a harmful effect on the 
human body, namely, the organs of hearing and the whole body through the central 
nervous system. It results in weakened attention, deteriorated memory, decreased 
response, and increased number of errors in work. Noise can be generated by operating 
equipment, air conditioning units, daylight illuminating devices, as well as spread from 
the outside. When working on a PC, the noise level in the workplace should not exceed 
50 dB. 
 Increased level of electromagnetic radiation 
        The screen and system blocks produce electromagnetic radiation. Its main part 
comes from the system unit and the video cable. According to [34], the intensity of the 
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electromagnetic field at a distance of 50 cm around the screen along the electrical 
component should be no more than: 
 in the frequency range 5 Hz - 2 kHz - 25 V / m; 
 in the frequency range 2 kHz - 400 kHz - 2.5 V / m. 
The magnetic flux density should be no more than: 
 in the frequency range 5 Hz - 2 kHz - 250 nT; 
 in the frequency range 2 kHz - 400 kHz - 25 nT. 
 Abnormally high voltage value in the circuit 
           Depending on the conditions in the room, the risk of electric shock to a person 
increases or decreases. Do not operate the electronic device in conditions of high 
humidity (relative air humidity exceeds 75% for a long time), high temperature (more 
than 35 ° C), the presence of conductive dust, conductive floors and the possibility of 
simultaneous contact with metal components connected to the ground and the metal 
casing of electrical equipment. The operator works with electrical devices: a computer 
(display, system unit, etc.) and peripheral devices. There is a risk of electric shock in the 
following cases: 
 with direct contact with current-carrying parts during computer repair; 
 when touched by non-live parts that are under voltage (in case of violation of 
insulation of current-carrying parts of the computer); 
 when touched with the floor, walls that are under voltage; 
 Short-circuited in high-voltage units: power supply and display unit. 





Table 6.3 – Upper limits for values of contact current and voltage 
 Voltage, V Current, mA 
Alternate,  50 Hz 2 0.3 
Alternate,  400 Hz 3 0.4 
Direct 8 1.0 
 Insufficient illumination of the working area 
           Light sources can be both natural and artificial. The natural source of the light in 
the room is the sun, artificial light are lamps. With long work in low illumination 
conditions and in violation of other parameters of the illumination, visual perception 
decreases, myopia, eye disease develops, and headaches appear. 
          According to the standard, the illumination on the table surface in the area of the 
working document should be 300-500 lux. Lighting should not create glare on the surface 
of the monitor. Illumination of the monitor surface should not be more than 300 lux. 
           The brightness of the lamps of common light in the area with radiation angles 
from 50 to 90° should be no more than 200 cd/m, the protective angle of the lamps should 
be at least 40°. The safety factor for lamps of common light should be assumed to be 1.4. 
The ripple coefficient should not exceed 5%. 
 Increased levels of ionizing radiation 
           Ionizing radiation is radiation that could ionize molecules and atoms. This effect 
is widely used in energetics and industry. However, there is health hazard. In living 
tissue, this radiation could damage cells that result in two types of effects. Deterministic 
effects (harmful tissue reactions) due to exposure with high doses and stochastic effects 
due to DNA destruction and mutations (for example, induction of cancer). 




 keep individual radiation doses from all radiation sources not higher than 
permissible exposure; 
 forbid all activity with using radiation sources if profit is low than risk of possible 
hazard; 
Keep individual radiation doses from all radiation sources as low as possible. 
There are two groups of people related to work with radiation: personnel, who works 
with ionizing radiation, and population (see Table 6.4). 





20 mSv per year in average 
during 5 years, but not higher 
than 50 mSv per year 
1 mSv per year in average 
during 5 years, but not higher 
than 5 mSv per year 
Equivalent dose 
per year in eye’s 
lens 
150 mSv 15 mSv 
skin 500 mSv 50 mSv 
Hands and feet 500 mSv 50 mSv 
 
       Effective dose for personnel must not exceed 1000 mSv for 50 years of working 
activity, and for population must not exceed 70 mSv for 70 years of life. 
     In addition, for women from personnel of age below 45 years there is limit of 1 mSv 
per month of equivalent dose on lower abdomen. During gestation and breast feeding 
women must not work with radiation sources. 
     For students older than 16, who uses radiation sources in study process or who is in 
rooms with increased level of ionizing radiation, dose limits are quarter part of dose 
limits of personnel. 
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6.4.3 Justification of measures to reduce the levels of exposure to hazardous and 
harmful factors on the researcher 
 Deviation of microclimate indicators 
The measures for improving the air environment in the production room include: 
the correct organization of ventilation and air conditioning, heating of room. Ventilation 
can be realized naturally and mechanically. In the room, the following volumes of outside 
air must be delivered:  
- at least 30 m3 per hour per person for the volume of the room up to 20m3 per 
person;  
- natural ventilation is allowed for the volume of the room more than 40 m 3 
per person and if there is no emission of harmful substances. 
The heating system must provide sufficient, constant and uniform heating of the 
air. Water heating should be used in rooms with increased requirements for clean air.  
The parameters of the microclimate in the laboratory regulated by the central 
heating system, have the following values: humidity 40%, air speed 0.1 m / s, summer 
temperature 20-25 ° C, in winter 13-15 ° C. Natural ventilation is provided in the 
laboratory. Air enters and leaves through the cracks, windows, doors. The main 
disadvantage of such ventilation is that the fresh air enters the room without preliminary 
cleaning and heating. 
 Excessive noise 
In research audiences, there are various kinds of noises that are generated by both 
internal and external noise sources. The internal sources of noise are working equipment, 
personal computer, printer, ventilation system, as well as computer equipment of other 
engineers in the audience. If the maximum permissible conditions are exceeded, it is 
sufficient to use sound-absorbing materials in the room (sound-absorbing wall and 
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ceiling cladding, window curtains). To reduce the noise penetrating outside the premises, 
install seals around the perimeter of the doors and windows. 
 Increased level of electromagnetic radiation 
There are the following ways to protect against EMF: 
- increase the distance from the source (the screen should be at least 50 cm from 
the user); 
- the use of pre-screen filters, special screens and other personal protective 
equipment. 
When working with a computer, the ionizing radiation source is a display. Under 
the influence of ionizing radiation in the body, there may be a violation of normal blood 
coagulability, an increase in the fragility of blood vessels, a decrease in immunity, etc. 
The dose of irradiation at a distance of 20 cm to the display is 50 µrem / hr. According 
to the norms [28], the design of the computer should provide the power of the exposure 
dose of x-rays at any point at a distance of 0.05 m from the screen no more than 100 µR 
/ h. 
Fatigue of the organs of vision can be associated with both insufficient 
illumination and excessive illumination, as well as with the wrong direction of light. 
 Increased levels of ionizing radiation 
In case of radiation accident, responsible personnel must take all measures to 
restore control of radiation sources and reduce to minimum radiation doses, number of 
irradiated persons, radioactive pollution of the environment, economic and social losses 
caused with radioactive pollution. 
Radiation control is a main part of radiation safety and radiation protection.  It is 
aimed at not exceeding the established basic dose limits and permissible levels of 
radiation, obtaining the necessary information to optimize protection and making 
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decisions about interference in the case of radiation accidents, contamination of the 
environment and buildings with radionuclides. 
The radiation control is control of: 
• Radiation characteristics of radiation sources, pollution in air, liquid and solid 
wastes. 
• Radiation factors developed with technological processes in working places 
and environment. 
• Radiation factors of contaminated environment. 
• Irradiation dose levels of personnel and population. 
The main controlled parameters are: 
• Annual effective and equivalent doses 
• intake and body content of radionuclides 
• volume or specific activity of radionuclides in air, water, food products, 
building materials and etc. 
• radioactive contamination of skin, clothes, footwear, working places and etc. 
• dose and power of external irradiation. 
• particles and photons flux density. 
Radiation protection office establish control levels of all controlled parameters in 
according to not exceed dose limits and keep dose levels as low as possible. In case of 
exceeding control levels radiation protection officers start investigation of exceed causes 
and take actions to eliminate this exceeding. 
During planning and implementation of radiation safety precautions, taking any 
actions about radiation safety and analysis of effectiveness of mentioned action and 
precautions one must value radiation safety with next factors: 
• characteristics of radioactive contamination of the environment; 
• probability of radiation accidents and scale of accidents; 
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• degree of readiness to effective elimination of radiation accidents and its 
aftermathches;  
• number of persons irradiated with doses higher than controlled limits of doses; 
• analysis of actions for providing radiation safety, meeting requirements, rules, 
standards of radiation safety; 
• analysis of irradiation doses obtained by groups of population from all ionizing 
radiation sources. 
 Abnormally high voltage value in the circuit 
Measures to ensure the electrical safety of electrical installations: 
- disconnection of voltage from live parts, on which or near to which work will 
be carried out, and taking measures to ensure the impossibility of applying voltage to the 
workplace; 
- posting of posters indicating the place of work; 
- electrical grounding of the housings of all installations through a neutral wire; 
- coating of metal surfaces of tools with reliable insulation; 
- inaccessibility of current-carrying parts of equipment (the conclusion in the 
case of electroporating elements, the conclusion in the body of current-carrying parts) 
[49]. 
 Insufficient illumination of the working area 
Desktops should be placed in such a way that the monitors are oriented sideways 
to the light openings, so that natural light falls mainly on the left. 
Also, as a means of protection to minimize the impact of the factor, local lighting 
should be installed due to insufficient lighting, window openings should be equipped 




6.5 Ecological safety 
6.5.1  Analysis of the impact of the research object on the environment 
            Sources of ionizing radiation used in medicine could be divided into two groups: 
radioactive substances and radiation generators. The difference is that radiation 
generators like accelerators and x-ray tubes emit ionizing radiation only when they are 
turned on.   In ordinary work with necessary safety precautions, there are insignificant 
impact of using sources of ionizing radiation on environment. The immediate effect of 
ionizing radiation is ionization of air in room, but after a specified time the ionization 
disappears. 
          The danger of using radioactive materials could occur only in accidents with 
stealing and loosing these materials due to high toxicity. 
6.5.2  Analysis of the environmental impact of the research process 
       Process of investigation itself in the thesis do not have essential effect on 
environment. One of hazardous waste is fluorescent lamps. Mercury in fluorescent lamps 
is a hazardous substance and its improper disposal greatly poisons the environment. 
          Outdated devices go to an enterprise that has the right to process wastes. It is 
possible to isolate precious metals with a purity in the range of 99.95–99.99% from 
computer components. A closed production cycle consists of the following stages: 
primary sorting of equipment; the allocation of precious, ferrous and non-ferrous metals 
and other materials; melting; refining and processing of metals. Thus, there is an effective 
disposal of computer devices. 
6.5.3 Justification of environmental protection measures 
          Pollution reduction is possible due to the improvement of devices that produces 
electricity, the use of more economical and efficient technologies, the use of new 
methods for generating electricity and the introduction of modern methods and methods 
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for cleaning and neutralizing industrial waste. In addition, this problem should be solved 
by efficient and economical use of electricity by consumers themselves. This is the use 
of more economical devices, as well as efficient regimes of these devices. This also 
includes compliance with production discipline in the framework of the proper use of 
electricity [51]. Simple conclusion is that it is necessary to strive to reduce energy 
consumption, to develop and implement systems with low energy consumption. In 
modern computers, modes with reduced power consumption during long-term idle are 
widely used. 
6.6 Safety in emergency 
6.6.1 Analysis of probable emergencies that may occur at the workplace during 
research.  
The fire is the most probable emergency in our life. Possible causes of fire: 
 malfunction of current-carrying parts of installations; 
 work with open electrical equipment; 
 short circuits in the power supply; 
 non-compliance with fire safety regulations; 
 presence of combustible components: documents, doors, tables, cable 
insulation,  
Activities on fire prevention are divided into: organizational, technical, operational and 
regime. 
6.6.2 Substantiation of measures for the prevention of emergencies and the 
development of procedures in case of emergencies 
          Organizational measures provide for correct operation of equipment, proper 
maintenance of buildings and territories, fire instruction for workers and employees, 
training of production personnel for fire safety rules, issuing instructions, posters, and 
the existence of an evacuation plan. 
105 
  
         The technical measures include compliance with fire regulations, norms for the 
design of buildings, the installation of electrical wires and equipment, heating, 
ventilation, lighting, the correct placement of equipment. The regime measures include 
the establishment of rules for the organization of work, and compliance with fire-fighting 
measures. To prevent fire from short circuits, overloads, etc., the following fire safety 
rules must be observed: 
 elimination of the formation of a flammable environment (sealing equipment, 
control of the air, working and emergency ventilation); 
 use in the construction and decoration of buildings of non-combustible or difficultly 
combustible materials; 
 the correct operation of the equipment (proper inclusion of equipment in the 
electrical supply network, monitoring of heating equipment); 
 correct maintenance of buildings and territories (exclusion of the source of ignition 
 prevention of spontaneous combustion of substances, restriction of fireworks); 
 training of production personnel in fire safety rules; 
 the publication of instructions, posters, the existence of an evacuation plan; 
 compliance with fire regulations, norms in the design of buildings, in the 
organization of electrical wires and equipment, heating, ventilation, lighting; 
 the correct placement of equipment; 
 Well-time preventive inspection, repair and testing of equipment. 
In the case of an emergency, it is necessary to: 
 inform the management (duty officer); 
 call the Emergency Service or the Ministry of Emergency Situations - tel. 112; 





        The aim of the this research was to evaluate the MLC parameters reproducibility of 
IMRT and VMAT plans, so according to the results that obtained, analyzed and discussed 
on the chapter 4, proved that research was succeed 99%, because the results answered 
the goal or objective of the research. The results proved that the MLC parameters 
reproducibility of IMRT and VMAT plans would affect the dose delivered to the patient. 
If so the measures must be taken to avoid the damage of the OARs and to maximize the 
tumor dose. The effect of reproducibility would be large when the segment width of the 
MLC increased. 
       Results were evaluated  in 2D and 3D-dose analysis through EPID panel based on 
the PerFRACTION software, through that the 3D-dose analysis showed  good results 
than 2D-dose analysis, due to that 3D-dose analysis  is better method for treatment than 
2D dose analysis when IMRT and VMAT were used, this is because had small 
reproducibility effect than 2D-dose analysis. The most conclusive results were obtained 
using the EPID device in which statistically significant correlation was identified in some 
segment widths. The large effect of the reproducibility in this research was observed on 
the thorax than in lung and prostate.    
       The results from EPID analyzed through the gamma index analysis and DVHs 
analysis, but through these analysis, observed that the gamma index analysis lacks 
specificity because it didn’t indicate the amount of volume where was covered by dose 
delivered. The research indicated that there was no directly relationship between the 
MLC parameters and electronic portal imaging device. EPID used to captures, to store 
and convert images into Portal images dose, although this occurred done by 100% but 
the experiment showed that EPID images associated with many artifacts. 
      Despite the few MLC parameters used, it can be concluded that the more complex 
the beam is, the greater the possibility that the delivered dose differs from the desired 
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one. However, this information is not yet sufficient to identify plans to be rejected in pre-
treatment QA tests.  For any case where the reproducibility affect would be large  for 
example in 2D-dose analysis, in order assure the more conformal dose  we need to redo 
again the planning and if after repetition you will get the same results  we need to change 
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APPENDIX I: Results for 2D-Dos analysis  






































0.5 05 x 11 208.6 0 0 145.9 0.471 0.468 -0.6 -0.3 
05 x12 265.7 0 0 129.3 0.616 0.626 1.6 1 
05 x13 318.6 0 0 120.1 0.397 0.390 -1.7 -0.7 
05 x14 0 0 0 151.8 0.300 0.300 1.6 0.5 
05 x 15 142.7 0 0 120.1 0.053 0.055 3.7 0.2 
1 10 x 11 208.6 0 0 127.5 0.476 0.524 10 4.8 
10 x 12 265.7 0 0 102.7 0.606 0.611 0.8 0.5 
10 x13 318.6 0 0 126.1 0.485 0.501 3.5 1.7 
10 x 14 0 0 0 64.4 0.237 0.233 -1.6 -0.4 
10 x15 142.7 0 0 121.4 0.065 0.068 6.2 0.4 
1.5 15 x 11 208.6 0 0 96.9 0.469 0.481 2.5 1.2 
15 x 12 265.7 0 0 95.3 0.538 0.548 1.8 1 
15 x 13 318.6 0 0 113.9 0.429 0.428 -0.2 -0.1 
15 x 14 0 0 0 70.1 0.283 0.272 -3.8 -1.1 
15 x 15 142.7 0 0 96.1 0.107 0.119 11.2 1.2 
2 20 x 11 208.6 0 0 95.9 0.467 0.497 6.4 3.0 
20 x 12 265.7 0 0 86.3 0.503 0.508 0.9 0.5 
20 x 13 318 0 0 125.5 0.465 0.461 -0.8 -0.4 
20 x 14 0 0 0 68 0.307 0.303 -1.3 -0.4 







0.5 1a005 180 0 0 333.5 1.114 1.109 0.4 0.5 
2a005 5 0 0 415 0.957 0.951 -0.6 -0.6 
1 1B010 180 0 0 301 0.961 0.950 1.1 1.1 
2B010 5 0 0 378.9 1.105 1.094 -1 -1.1 
1.5 1C015 180 0 0 267.6 0.925 0.934 0.9 0.9 
2C015 5 0 0 375.5 1.172 1.152 -1.6 -1.9 
2 1D020 180 0 0 270 1.007 0.976 -3.0 -3.1 






0.5 SWA05 200 345 345 186 0.979 0.980 0.1 0.1 
SWB05 65 345 345 199.2 1.150 1.175 2.1 2.5 
1 SWA10 200 345 345 158.9 1.019 1.066 4.6 4.7 
SWA10 65 345 345 173 1.144 1.139 -0.4 -0.5 
1.5 SWA15 200 345 345 158.9 1.019 1.030 1.0 1.1 
SWA15 65 345 345 173 1.144 1.135 -0.7 -0.9 
2 SWA20 200 345 345 203.9 0.951 1.058 11.2 10.7 























































05 x11 41750 67.79  19834 32.21 61584 
05 x12 34590 60.95 22158 39.05 56748 
05 x13 47765 67.12 23402 32.88 71167 
05 x 14 2182 38.01 44337 61.99 71519 




10 x 11 35827 57.85 26098 42.14 61926 
10 x 12 34635 60.12 22975 39.88 57610 
10 x13 52571 71.79 20658 28.21 73229 
10 x 14 30781 43.01 40749 56.94 71568 




15 x 11 42997 67.26 20927 32.74 63924 
15 x 12 32586 57.41 24175 42.59 56761 
15 x 13 51730 69.11 23126 30.89 74856 
15 x 14 36335 49.65 36847 50.35 73182 




20 x 11 29652 48.7 31233 51.30 31233 
20 x 12 27523 48.49 29237 51.51 56760 
20 x 13 47408 64.5 26096 35.5 73504 
20 x 14 32932 45 40251 55 73183 










1a005 4182 87.76 5833 12.24 47654 
2a005 47394 86.71 7264 13.29 54658 
 
1 
1B010 47328 90.30 5086 9.7 52414 
2B010 8063 14.55 47336 85.45 55399 
 
1.5 
1C015 47552 90.32 5096 9.68 52648 
2C015 43986 76.99 13148 23.01 57134 
 
2 
1D020 43286 83.71 8422 16.28 51708 










SWA05 2374 14.17 14378 85.83 16752 
SWB05 13591 94.73 756 5.27 14347 
 
1 
SWA10 12381 78.49 3392 21.27 15773 
SWB10 13642 86.79 2077 13.21 15719 
 
1.5 
SWA15 12430 78.85 3335 21.15 15765 
SWB15 13439 85.48 2282 14.52 15721 
 
2 
SWA20 11946 76.51 3667 23.49 15613 




Fig 3.4. Points passed and standardization for lung plans in 2D-Dose analysis  
 



















































% of  Mean  Passed Points  and Standard Deviation for Lung Plans 
Between 0.5 and 2cm  Sgment Width



















































% of Mean Passed Points and Standard Deviation  for 
Prostate Plans between 0.5 and 2cm Segment Widths
% of Mean Passed Points Standard deviation
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APPENDXI II: Results of 3D-dose analysis 











            
 
 






















Points passed in 3D- dose analysis for a lung plans 






























0.5 154962 99.39 947 0.61 155909 
1 141934 90.33 15197 9.87 157181 
1.5 152051 98.06 3003 1.94 155054 








0.5 23498 88.42 3076 11.58 26574 
1 24793 93.29 1782 6.7 26575 
1.5 25065 94.36 1499 5.65 26564 







0.5 174586 92.45 14265 7.55 188851 
1 162870 85.5 27612 14.49 190482 
1.5 160591 84.47 29533 15.53 190124 




Fig 3.6. Dose Volume Histogram for Lung Plans of 0.5 cm segment width   
 



















APPENDIXIII: Recalculating Results 
 
Fig 3.6 comparison of (2%, 2mm, TH=10%) and (3%, 3mm, TH=20%) gamma 
criterion in 2D-dose analysis for lung plans  
 
Fig 3.7 comparison of (2%, 2mm, TH=10%) and (3%, 3mm, TH=20%) gamma criterion 




























Comparison of (2%, 2mm, TH=10% and (3%, 3mm, TH=20%) 
Gamma Criterions in 2D- dose analysis for Lung Plans  




























Comparison of (2%, 2mm, TH=10%, 3%, 3mm, TH=20%) gamma 
criterion Prostate




Fig 3.8 comparison of (2%, 2mm, TH=10%) and (3%, 3mm, TH=20%) gamma criterion 


































Comparison of (2%, 2mm, TH=10%) and (3%, 3mm, TH=20%) gamma 
criterion Thorax plans
(2%,2mm, TH=10%) gamma criterion (3%, 3mm, TH=20%) gamma criterion
